Fondaparinux sodium
| Title | Journal |
|---|---|
| A specific antidote for reversal of anticoagulation by direct and indirect inhibitors of coagulation factor Xa. | Nature medicine 20130401 |
| The influence of fondaparinux on the diagnosis of postoperative deep vein thrombosis by soluble fibrin and D-dimer. | Thrombosis research 20121101 |
| Investigating the benefit of adding a vena cava filter to anticoagulation with fondaparinux sodium in patients with cancer and venous thromboembolism in a prospective randomized clinical trial. | Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 20121101 |
| Plasma accumulation of fondaparinux 2.5 mg in patients after total hip arthroplasty. | Journal of thrombosis and thrombolysis 20121101 |
| Corn trypsin inhibitor coating attenuates the prothrombotic properties of catheters in vitro and in vivo. | Acta biomaterialia 20121101 |
| Pharmacokinetics of fondaparinux 1.5 mg once daily in a real-world cohort of patients with renal impairment undergoing major orthopaedic surgery. | European journal of clinical pharmacology 20121001 |
| Treatment, survival, and thromboembolic outcomes of thrombotic storm in children. | The Journal of pediatrics 20121001 |
| Treatment outcomes of heparin-induced thrombocytopenia in subarachnoid hemorrhage patients: a 4-year, retrospective single-center review. | Neurocritical care 20121001 |
| Incidence and characteristics of asymptomatic distal deep vein thrombosis unexpectedly found at admission in an Internal Medicine setting. | Thrombosis research 20121001 |
| Inferior vena cava thrombectomy in a patient with heparin-induced thrombocytopenia via inflow occlusion technique on beating heart. | Interactive cardiovascular and thoracic surgery 20121001 |
| Efficacy and safety of rivaroxaban or fondaparinux thromboprophylaxis in major orthopedic surgery: findings from the ORTHO-TEP registry. | Journal of thrombosis and haemostasis : JTH 20121001 |
| Low molecular weight heparin inhibits plasma thrombin generation via direct targeting of factor IXa: contribution of the serpin-independent mechanism. | Journal of thrombosis and haemostasis : JTH 20121001 |
| Vaginal delivery in a parturient excessively anticoagulated with fondaparinux. | International journal of obstetric anesthesia 20121001 |
| Differential effects of fondaparinux and bemiparin on angiogenic and vasculogenesis-like processes. | Thrombosis research 20120901 |
| Sulfamate proton solvent exchange in heparin oligosaccharides: evidence for a persistent hydrogen bond in the antithrombin-binding pentasaccharide Arixtra. | Glycobiology 20120901 |
| The management of antithrombotic medication in skin surgery. | Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] 20120901 |
| Epidemiology, diagnosis, treatment and management of superficial-vein thrombosis of the legs. | Best practice & research. Clinical haematology 20120901 |
| Thrombolytic therapy for submassive pulmonary embolism. | Best practice & research. Clinical haematology 20120901 |
| Synthesis and anticoagulant activity of bioisosteric sulfonic-Acid analogues of the antithrombin-binding pentasaccharide domain of heparin. | Chemistry (Weinheim an der Bergstrasse, Germany) 20120820 |
| Designing allosteric regulators of thrombin. Monosulfated benzofuran dimers selectively interact with Arg173 of exosite 2 to induce inhibition. | Journal of medicinal chemistry 20120809 |
| Compartment syndrome due to massive leg hematoma after primary total hip arthroplasty: a previously unreported complication of fondaparinux. | The Journal of arthroplasty 20120801 |
| Development of both colorimetric and fluorescence heparinase activity assays using fondaparinux as substrate. | Analytical biochemistry 20120801 |
| Which antithrombin for whom? Identifying the patient population that benefits most from novel antithrombin agents. | Current cardiology reports 20120801 |
| Bivalirudin versus unfractionated heparin in percutaneous coronary interventions of patients having received initial fondaparinux treatment: a propensity matched study. | EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 20120801 |
| Comparative effectiveness of preventative therapy for venous thromboembolism after coronary artery bypass graft surgery. | Circulation. Cardiovascular interventions 20120801 |
| Practice guidelines for reversal of new and old anticoagulants. | Disease-a-month : DM 20120801 |
| In silico discovery of a compound with nanomolar affinity to antithrombin causing partial activation and increased heparin affinity. | Journal of medicinal chemistry 20120726 |
| Complete mass spectral characterization of a synthetic ultralow-molecular-weight heparin using collision-induced dissociation. | Analytical chemistry 20120703 |
| Cost-effectiveness of fondaparinux in patients with acute coronary syndrome without ST-segment elevation. | Arquivos brasileiros de cardiologia 20120701 |
| Reversing anticoagulant therapy. | Current drug discovery technologies 20120601 |
| Venous thromboembolism prevention with fondaparinux 1.5 mg in renally impaired patients undergoing major orthopaedic surgery. A real-world, prospective, multicentre, cohort study. | Thrombosis and haemostasis 20120601 |
| Successful desensitization with un-fractionated heparin in a patient with heparin allergy and tolerance to fondaparinux. | Asian Pacific journal of allergy and immunology 20120601 |
| [Thigh haematoma after sciatic nerve block and fondaparinux]. | Annales francaises d'anesthesie et de reanimation 20120501 |
| Postoperative prophylactic effect of fondaparinux for prevention of deep venous thrombosis after cemented total hip replacement: a comparative study. | Modern rheumatology 20120401 |
| In vitro study of the anticoagulant effects of edoxaban and its effect on thrombin generation in comparison to fondaparinux. | Thrombosis research 20120401 |
| Fondaparinux - data on efficacy and safety in special situations. | Thrombosis research 20120401 |
| Dose determination of fondaparinux in healthy cats. | American journal of veterinary research 20120401 |
| How should I treat a 'swinging' left main thrombosis complicating coronary angioplasty in an obese, diabetic, elderly woman treated with fondaparinux? | EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 20120401 |
| Preventing venous thromboembolism in hospitalized patients with cancer: improving compliance with clinical practice guidelines. | American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20120315 |
| Treatment for superficial thrombophlebitis of the leg. | The Cochrane database of systematic reviews 20120314 |
| Successful use of fondaparinux for bridging early after aortic and mitral mechanical heart valve replacement. | The Annals of pharmacotherapy 20120301 |
| A closer look at the nitrogen next door: 1H-15N NMR methods for glycosaminoglycan structural characterization. | Journal of magnetic resonance (San Diego, Calif. : 1997) 20120301 |
| [Preclinical and clinical data of the synthetic Xa inhibitor fondaparinux (Arixtra(®))]. | Nihon yakurigaku zasshi. Folia pharmacologica Japonica 20120301 |
| Venous thrombosis in emergency department: diagnosis, treatment, and disposition. | European review for medical and pharmacological sciences 20120301 |
| Fondaparinux for isolated superficial vein thrombosis of the legs: a cost-effectiveness analysis. | Chest 20120201 |
| Promise of factor Xa inhibition in acute coronary syndromes. | Current cardiology reports 20120201 |
| Evaluation of the duration of thromboembolic prophylaxis after high-risk orthopaedic surgery: the ETHOS observational study. | Thrombosis and haemostasis 20120201 |
| Post-discharge compliance to venous thromboembolism prophylaxis in high-risk orthopaedic surgery: results from the ETHOS registry. | Thrombosis and haemostasis 20120201 |
| Association between venous thromboembolism and plasma levels of both soluble fibrin and plasminogen-activator inhibitor 1 in 170 patients undergoing total hip arthroplasty. | Acta orthopaedica 20120201 |
| Increased fibrinolysis increases bleeding in orthopedic patients receiving prophylactic fondaparinux. | International journal of hematology 20120201 |
| Evidence-based management of anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. | Chest 20120201 |
| Prevention of VTE in nonsurgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. | Chest 20120201 |
| Parenteral anticoagulants: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. | Chest 20120201 |
| Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. | Chest 20120201 |
| Application, tolerance and safety of fondaparinux therapy in a German hospital: a prospective single-centre experience. | Thrombosis research 20120101 |
| A case of unsuccessful treatment of heparin-induced thrombocytopenia (HIT) with fondaparinux. | Journal of thrombosis and thrombolysis 20120101 |
| Enoxaparin and fondaparinux attenuates endothelial damage in endotoxemic rats. | The journal of trauma and acute care surgery 20120101 |
| Fondaparinux versus enoxaprin in the management of acute coronary syndromes in Switzerland: A cost comparison analysis. | Swiss medical weekly 20120101 |
| [Roles of coagulation pathway and factor Xa in chronic kidney disease (CKD)]. | Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 20120101 |
| Hitting back HIT. | Annals of cardiac anaesthesia 20120101 |
| [Risk factor for residual deep vein thrombosis after fondaparinux administration in patients with postoperative replacement arthroplasty]. | Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan 20120101 |
| Anticoagulant therapy during pregnancy for maternal and fetal acquired and inherited thrombophilia. | Current medicinal chemistry 20120101 |
| Risk factors for pulmonary embolism and the effects of fondaparinux after total hip and knee arthroplasty: a retrospective observational study with use of a national database in Japan. | The Journal of bone and joint surgery. American volume 20111221 |
| Mechanism of catheter thrombosis: comparison of the antithrombotic activities of fondaparinux, enoxaparin, and heparin in vitro and in vivo. | Blood 20111215 |
| FondaKIDS: a prospective pharmacokinetic and safety study of fondaparinux in children between 1 and 18 years of age. | Pediatric blood & cancer 20111201 |
| Old and new antithrombotic drugs in neonates and infants. | Seminars in fetal & neonatal medicine 20111201 |
| Fondaparinux treatment of acute heparin-induced thrombocytopenia confirmed by the serotonin-release assay: a 30-month, 16-patient case series. | Journal of thrombosis and haemostasis : JTH 20111201 |
| Fondaparinux in acute heparin-induced thrombocytopenia: a case series. | Journal of thrombosis and haemostasis : JTH 20111201 |
| Immunogenic but effective: the HIT-fondaparinux brain puzzler. | Journal of thrombosis and haemostasis : JTH 20111201 |
| Comparison of antithrombotic efficacy between edoxaban, a direct factor Xa inhibitor, and fondaparinux, an indirect factor Xa inhibitor under low and high shear rates. | Thrombosis and haemostasis 20111201 |
| Advances in anticoagulation: focus on dabigatran, an oral direct thrombin inhibitor. | Journal of cardiothoracic and vascular anesthesia 20111201 |
| Heparin-induced thrombocytopenia: comparison between response to fondaparinux and lepirudin. | International journal of clinical pharmacy 20111201 |
| Transfusions, major bleeding, and prevention of venous thromboembolism with enoxaparin or fondaparinux in thoracic surgery. | Thrombosis and haemostasis 20111201 |
| Venous thromboembolism prophylaxis for medical service-mostly cancer-patients at hospital discharge. | The American journal of medicine 20111201 |
| Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps). | PLoS computational biology 20111201 |
| Safety and efficacy of antiplatelet and antithrombotic therapy in acute coronary syndrome patients with chronic kidney disease. | Journal of the American College of Cardiology 20111122 |
| Areas of uncertainty in prophylaxis of venous thromboembolism in unselected subjects. | Southern medical journal 20111101 |
| Fondaparinux and isolated superficial-vein thrombosis. Of little interest. | Prescrire international 20111101 |
| [New anticoagulants]. | La Revue du praticien 20111101 |
| Chemoenzymatic synthesis of homogeneous ultralow molecular weight heparins. | Science (New York, N.Y.) 20111028 |
| Detection of the 1H and 15N NMR resonances of sulfamate groups in aqueous solution: a new tool for heparin and heparan sulfate characterization. | Analytical chemistry 20111015 |
| A rare and undesirable complication of heparin-induced thrombocytopenia: acute massive pulmonary embolism. | Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 20111001 |
| Long-term anticoagulation with fondaparinux in a patient with a mechanical heart valve. | Annals of hematology 20111001 |
| Trousseau's syndrome in a patient with adenocarcinoma of unknown primary and therapy-resistant venous thrombosis treated with dabigatran and fondaparinux. | British journal of clinical pharmacology 20111001 |
| The risk for cross-reactions after a cutaneous delayed-type hypersensitivity reaction to heparin preparations is independent of their molecular weight: a systematic review. | Contact dermatitis 20111001 |
| IL-10 modulates fondaparinux inhibition of monocyte-induced thrombin generation. | Journal of thrombosis and thrombolysis 20111001 |
| Randomized trial of fondaparinux versus heparin to prevent graft failure after coronary artery bypass grafting: the Fonda CABG study. | Journal of thrombosis and thrombolysis 20111001 |
| Anticoagulating obese patients in the modern era. | British journal of haematology 20111001 |
| Refractory venous thrombus propagation in the setting of therapeutic anticoagulation. | American journal of physical medicine & rehabilitation 20111001 |
| Monitoring for anti-Xa activity for prophylactic administration of Fondaparinux in patients with artificial joint replacement. | International journal of hematology 20111001 |
| Italian intersociety consensus statement on antithrombotic prophylaxis in hip and knee replacement and in femoral neck fracture surgery. | Minerva anestesiologica 20111001 |
| Initiation and reinitiation of anticoagulation therapy. | Seminars in hematology 20111001 |
| [Looking for the best molecule. A short history of anticoagulants]. | Revue des maladies respiratoires 20111001 |
| [Safety and economics of fondaparinux administration in the laparoscopic surgery]. | Masui. The Japanese journal of anesthesiology 20111001 |
| Effect of fondaparinux prophylaxis on anti-factor Xa concentrations in patients with morbid obesity. | American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20110915 |
| Aspirin for lower limb arthroplasty thromboprophylaxis: review of international guidelines. | Irish journal of medical science 20110901 |
| Effects of antithrombotic drugs fondaparinux and tinzaparin on in vitro proliferation and osteogenic and chondrogenic differentiation of bone-derived mesenchymal stem cells. | Journal of orthopaedic research : official publication of the Orthopaedic Research Society 20110901 |
| [Comparison of platelet monitoring in patients receiving thromboprophylaxis with fondaparinux or a low molecular weight heparin. The Ariane study]. | Presse medicale (Paris, France : 1983) 20110901 |
| Bleeding risk and reversal strategies for old and new anticoagulants and antiplatelet agents. | Journal of thrombosis and haemostasis : JTH 20110901 |
| Bioavailability of fondaparinux to critically ill patients. | Journal of critical care 20110801 |
| Prevalence and risk of preexisting heparin-induced thrombocytopenia antibodies in patients with acute VTE. | Chest 20110801 |
| Anticoagulants influence the in vitro activity and composition of shock lymph but not its in vivo activity. | Shock (Augusta, Ga.) 20110801 |
| How serious a problem is bleeding in patients with acute coronary syndromes? | Current cardiology reports 20110801 |
| Use and outcomes of venous thromboembolism prophylaxis after spinal fusion surgery. | Journal of thrombosis and haemostasis : JTH 20110701 |
| Differential coagulation inhibitory effect of fondaparinux, enoxaparin and unfractionated heparin in cell models of thrombin generation. | Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 20110701 |
| Prolonged anticoagulation with fondaparinux for mechanical cardiac valves in the setting of intracranial hemorrhage. | The Journal of heart valve disease 20110701 |
| Detection of a left atrial thrombus under fondaparinux treatment: a case report. | Current drug safety 20110701 |
| Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer. | The Cochrane database of systematic reviews 20110615 |
| Use of recombinant factor VIIa (NovoSeven(®)) in 8 patients with ongoing life-threatening bleeding treated with fondaparinux. | Acute cardiac care 20110601 |
| Effect of edoxaban on markers of coagulation in venous and shed blood compared with fondaparinux. | Thrombosis and haemostasis 20110601 |
| Prophylaxis of venous thromboembolism: low molecular weight heparin compared to the selective anticoagulants rivaroxaban, dabigatran and fondaparinux. | International angiology : a journal of the International Union of Angiology 20110601 |
| Heparin promotes platelet responsiveness by potentiating αIIbβ3-mediated outside-in signaling. | Blood 20110505 |
| Future anticoagulants in interventional cardiology: anti-IXa and anti-Xa agents in percutaneous coronary intervention. | Future cardiology 20110501 |
| Advances in cardiology: clinical trial update. | Future cardiology 20110501 |
| Functionality of fondaparinux (pentasaccharide) depends on clinical antithrombin levels. | Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 20110401 |
| Preventing postsurgical venous thromboembolism: pharmacological approaches. | Seminars in thrombosis and hemostasis 20110401 |
| Effects on fibrin network porosity of anticoagulants with different modes of action and reversal by activated coagulation factor concentrate. | British journal of haematology 20110301 |
| Comparison of safety and efficacy between fondaparinux and nadroparin in non-ST elevation acute coronary syndromes. | Chinese medical journal 20110301 |
| Changes in the concentration of monocytic chemotaxic protein-1 in patients with unstable angina treated with arixtra. | Bulletin of experimental biology and medicine 20110301 |
| Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer. | The Cochrane database of systematic reviews 20110216 |
| Development of a recombinant antithrombin variant as a potent antidote to fondaparinux and other heparin derivatives. | Blood 20110210 |
| Effects of fondaparinux and a direct factor Xa inhibitor TAK-442 on platelet-associated prothrombinase in the balloon-injured artery of rats. | Journal of cardiovascular pharmacology 20110201 |
| Elevated factor VIII enhances thrombin generation in the presence of factor VIII-deficiency, factor XI-deficiency or fondaparinux. | Thrombosis research 20110201 |
| New anticoagulant agents in acute coronary syndromes. | Heart (British Cardiac Society) 20110201 |
| Antithrombotic therapy in ST-segment elevation myocardial infarction. | Expert opinion on pharmacotherapy 20110201 |
| Recent findings in the epidemiology, diagnosis and treatment of superficial-vein thrombosis. | Thrombosis research 20110201 |
| [Recent advances in the treatment of superficial vein thrombosis and extracranial carotid artery stenosis]. | Deutsche medizinische Wochenschrift (1946) 20110201 |
| Is routine chemical thromboprophylaxis after total hip replacement really necessary in a Japanese population? | The Journal of bone and joint surgery. British volume 20110201 |
| Direct thrombin and factor Xa inhibitors in children: a quest for new anticoagulants for children. | Wiener medizinische Wochenschrift (1946) 20110201 |
| Treatment of superficial thrombophlebitis. | The New England journal of medicine 20110127 |
| Treatment of superficial thrombophlebitis. | The New England journal of medicine 20110127 |
| Heparin: a potent inhibitor of hepcidin expression in vitro and in vivo. | Blood 20110120 |
| Factor Xa inhibitors for acute coronary syndromes. | The Cochrane database of systematic reviews 20110119 |
| Inter-individual variability of effect of 7 low molecular weight antithrombin-dependent anticoagulants studied in vitro with calibrated automated thrombography. | Thrombosis research 20110101 |
| Efficacy of prothrombin complex concentrate to reverse the anticoagulant effect of the pentasaccharide fondaparinux in a rabbit model. | Thrombosis and haemostasis 20110101 |
| Early postoperative bleeding in polytrauma patients treated with fondaparinux: literature review and institutional experience. | Current vascular pharmacology 20110101 |
| Interindividual variability of in vitro response to anticoagulants. | Thrombosis research 20110101 |
| Fondaparinux cross-reacts with heparin antibodies in vitro in a patient with fondaparinux-related thrombocytopenia. | Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 20110101 |
| Delayed hypersensitivity challenged by subcutaneous Bemiparin. | Allergologia et immunopathologia 20110101 |
| Is there a role for fondaparinux in perioperative bridging? | American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20110101 |
| Prospective study on the efficacies of fondaparinux and enoxaparin in preventing venous thromboembolism after hip fracture surgery. | Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association 20110101 |
| [A case of a flapping infected thrombus in the internal jugular vein, septic pneumonias and heparin-induced thrombocytopaenia]. | Vnitrni lekarstvi 20110101 |
| Heparin-induced thrombocytopenia in the ICU: an overview. | Critical care (London, England) 20110101 |
| Multidetector-row computed tomography-based clinical assessment of fondaparinux for treatment of acute pulmonary embolism and acute deep vein thrombosis in Japanese patients. | Circulation journal : official journal of the Japanese Circulation Society 20110101 |
| Use of fondaparinux in a pregnant woman with pulmonary embolism and heparin-induced thrombocytopenia. | Medical science monitor : international medical journal of experimental and clinical research 20110101 |
| Roles of coagulation pathway and factor Xa in the progression of diabetic nephropathy in db/db mice. | Biological & pharmaceutical bulletin 20110101 |
| [Fondaparinux treatment in heparin induced thrombocytopenia:a case report]. | Tuberkuloz ve toraks 20110101 |
| Deep venous thrombosis after mini-posterior total hip arthroplasty in Japanese patients. | Hip international : the journal of clinical and experimental research on hip pathology and therapy 20110101 |
| Oral fondaparinux: use of lipid nanocapsules as nanocarriers and in vivo pharmacokinetic study. | International journal of nanomedicine 20110101 |
| Fondaparinux for the treatment of acute heparin-induced thrombocytopenia: a single-center experience. | Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 20101201 |
| [Use of fondaparinux during hemodialysis in heparin-induced thrombocytopenia. About a new observation]. | Nephrologie & therapeutique 20101201 |
| A competitive binding study of chemokine, sulfated receptor, and glycosaminoglycan interactions by nano-electrospray ionization mass spectrometry. | Analytical biochemistry 20101201 |
| The new oral anticoagulants, do they change the benefit vs. risk for thromboprophylaxis in association to ambulatory surgery? | Current opinion in anaesthesiology 20101201 |
| New synthetic antithrombotic agents for venous thromboembolism: pentasaccharides, direct thrombin inhibitors, direct Xa inhibitors. | Clinics in chest medicine 20101201 |
| Fondaparinux with UnfracTionated heparin dUring Revascularization in Acute coronary syndromes (FUTURA/OASIS 8): a randomized trial of intravenous unfractionated heparin during percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndromes initially treated with fondaparinux. | American heart journal 20101201 |
| Efficacy and safety of fondaparinux in patients with ST-segment elevation myocardial infarction across the age spectrum. Results from the Organization for the Assessment of Strategies for Ischemic Syndromes 6 (OASIS-6) trial. | American heart journal 20101201 |
| Development and in vivo bioavailability study of an oral fondaparinux delivery system. | European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 20101120 |
| Differential inhibitory effect of fondaparinux on the procoagulant potential of intact monocytes and monocyte-derived microparticles. | Journal of thrombosis and thrombolysis 20101101 |
| Successful surgical management of massive pulmonary embolism during the second trimester in a parturient with heparin-induced thrombocytopenia. | Interactive cardiovascular and thoracic surgery 20101101 |
| Fondaparinux thromboprophylaxis-associated heparin-induced thrombocytopenia syndrome complicated by arterial thrombotic stroke. | Thrombosis and haemostasis 20101101 |
| Acute pulmonary embolism. Part 2: treatment. | Nature reviews. Cardiology 20101101 |
| Pulmonary embolectomy in heparin-induced thrombocytopenia and thrombosis? Safety of heparin use. | Interactive cardiovascular and thoracic surgery 20101101 |
| Korean guidelines for the prevention of venous thromboembolism. | Journal of Korean medical science 20101101 |
| Choosing the right heparin prophylaxis strategy in medical patients at risk for developing VTE: an evidence-based approach. | Hospital practice (1995) 20101101 |
| Treating DVT: answers to 7 key questions. | The Journal of family practice 20101101 |
| A pilot retrospective comparison of fondaparinux and enoxaparin for the prevention of venous thromboembolism (VTE) in patients with stroke. | Medicine and health, Rhode Island 20101101 |
| The HIT treatment in a cardiac surgery patient. | International journal of cardiology 20101029 |
| Does aspirin have a role in venous thromboembolism prophylaxis in total knee arthroplasty patients? | The Journal of arthroplasty 20101001 |
| Incidence and time course of asymptomatic deep vein thrombosis with fondaparinux in patients undergoing total joint arthroplasty. | Thrombosis research 20101001 |
| Successful use of fondaparinux in a patient with a mechanical heart valve replacement and a history of heparin-induced thrombocytopenia. | Journal of thrombosis and thrombolysis 20101001 |
| Layer-by-layer surface modification of lipid nanocapsules. | European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 20101001 |
| Low allergenic potential with fondaparinux: results of a prospective investigation. | Mayo Clinic proceedings 20101001 |
| The treatment of venous thromboembolism in patients with cancer. | Internal and emergency medicine 20101001 |
| [Comparison of therapeutic efficacy between fondaparinux and low molecular weight heparin for patients with acute coronary syndrome]. | Zhongguo wei zhong bing ji jiu yi xue = Chinese critical care medicine = Zhongguo weizhongbing jijiuyixue 20101001 |
| Fondaparinux: does it cause HIT? Can it treat HIT? | Expert review of hematology 20101001 |
| Fondaparinux for the treatment of superficial-vein thrombosis in the legs. | The New England journal of medicine 20100923 |
| Superficial phlebitis and phase 3.5 trials. | The New England journal of medicine 20100923 |
| Low-dose vs standard-dose unfractionated heparin for percutaneous coronary intervention in acute coronary syndromes treated with fondaparinux: the FUTURA/OASIS-8 randomized trial. | JAMA 20100922 |
| DVT prophylaxis: better living through chemistry: affirms. | Orthopedics 20100907 |
| Treatment options in heparin-induced thrombocytopenia. | Current opinion in hematology 20100901 |
| Thrombocytopenia during fondaparinux prophylaxis: HIT or something different? | Internal and emergency medicine 20100801 |
| Fondaparinux as an alternative anticoagulant therapy during pregnancy. | Journal of thrombosis and haemostasis : JTH 20100801 |
| Anticoagulation by factor Xa inhibitors. | Journal of thrombosis and haemostasis : JTH 20100801 |
| Population pharmacokinetics of fondaparinux administered at prophylactic doses after major orthopaedic surgery in everyday practice. | Thrombosis and haemostasis 20100801 |
| Delayed hypersensitivity to heparin in a patient with cancer: fondaparinux may be safe but needs to be tested. | Contact dermatitis 20100801 |
| Pharmacologic therapy for non ST-segment elevation acute coronary syndromes: focus on antithrombotic therapy. | Cardiovascular drugs and therapy 20100801 |
| Acute pulmonary embolism. | The New England journal of medicine 20100715 |
| Venous thromboembolism and cancer: a systematic review. | Journal of thrombosis and thrombolysis 20100701 |
| Fondaparinux therapy in a hemodialysis patient with heparin-induced thrombocytopenia type II. | American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20100701 |
| The complex clinical picture of side effects to anticoagulation. | The Medical clinics of North America 20100701 |
| [Fondaparinux and lepirudin as therapeutic alternatives in a disseminated eczematous skin reaction to low-molecular-weight heparin]. | Actas dermo-sifiliograficas 20100701 |
| [A new deal with new anticoagulants?]. | Journal des maladies vasculaires 20100601 |
| Deep vein thrombosis: how long will it remain? | Journal of anesthesia 20100601 |
| Old versus new anticoagulants: focus on pharmacology. | Recent patents on cardiovascular drug discovery 20100601 |
| Adverse drug events associated with disorders of coagulation. | Critical care medicine 20100601 |
| Fondaparinux (Arixtra(R)), a safe alternative for the treatment of patients with heparin-induced thrombocytopenia? | Journal of pharmacy practice 20100601 |
| [Results of ENDORSE-2-HUNGARIA study. Repeated assessment of the prevalence of venous thromboembolism risk and prophylaxis in acute hospital care setting]. | Orvosi hetilap 20100523 |
| Clinical and management challenges in preventing venous thromboembolism in health systems: a case-based panel discussion. | American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20100515 |
| Issues in assessing and reducing the risk for venous thromboembolism. | American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20100515 |
| Severe bleeding secondary to misuse of fondaparinux: a case report. | Journal of thrombosis and thrombolysis 20100501 |
| Development and evaluation of a fluorescence microplate assay for quantification of heparins and other sulfated carbohydrates. | Journal of pharmaceutical and biomedical analysis 20100501 |
| Deep vein and intracardiac thrombosis during the post-partum period in Behçet's disease. | International journal of hematology 20100501 |
| [Fondaparinux in the treatment of acute coronary syndromes]. | Zhonghua xin xue guan bing za zhi 20100501 |
| Early discharge of patients with venous thromboembolism: implications regarding therapy. | Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 20100401 |
| Paroxysmal nocturnal hemoglobinuria following alemtuzumab immunosuppressive therapy for myelodysplastic syndrome and complicated by recurrent life-threatening thrombosis despite anticoagulation: successful intervention with eculizumab and fondaparinux. | Leukemia research 20100401 |
| Inhibitors of slit protein interactions with the heparan sulphate proteoglycan glypican-1: potential agents for the treatment of spinal cord injury. | Clinical and experimental pharmacology & physiology 20100401 |
| Fondaparinux or enoxaparin: a comparative study of postoperative bleeding in coronary artery bypass grafting surgery. | Scandinavian cardiovascular journal : SCJ 20100401 |
| Assessment of laboratory assays to measure rivaroxaban--an oral, direct factor Xa inhibitor. | Thrombosis and haemostasis 20100401 |
| Update on fondaparinux: role in management of thromboembolic and acute coronary events. | Cardiovascular & hematological agents in medicinal chemistry 20100401 |
| Fondaparinux in major orthopedic surgical patients. | Internal and emergency medicine 20100401 |
| Neuraxial anesthesia in obstetric patients receiving anticoagulant and antithrombotic drugs. | International journal of obstetric anesthesia 20100401 |
| Recombinant factor VIIa to manage major bleeding from newer parenteral anticoagulants. | The Annals of pharmacotherapy 20100401 |
| VTE prophylaxis for the medical patient: where do we stand? - a focus on cancer patients. | Thrombosis research 20100401 |
| Retrospective evaluation of venous thromboembolism prophylaxis in the adult cancer population. | Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 20100301 |
| Treatment of heparin-induced thrombocytopenia after cardiac surgery: preliminary experience with fondaparinux. | The Journal of thoracic and cardiovascular surgery 20100301 |
| Anti-PF4/heparin antibody formation postorthopedic surgery thromboprophylaxis: the role of non-drug risk factors and evidence for a stoichiometry-based model of immunization. | Journal of thrombosis and haemostasis : JTH 20100301 |
| Extended prophylaxis of venous thromboembolism with fondaparinux in patients undergoing major orthopaedic surgery in Italy: a cost-effectiveness analysis. | Internal and emergency medicine 20100201 |
| Comparison of the anticoagulant intensities of fondaparinux and enoxaparin in the Organization to Assess Strategies in Acute Ischemic Syndromes (OASIS)-5 trial. | Journal of thrombosis and haemostasis : JTH 20100201 |
| Routine use of fondaparinux in acute coronary syndromes: a 2-year multicenter experience. | American heart journal 20100201 |
| Anticoagulant therapy for percutaneous coronary intervention. | Circulation. Cardiovascular interventions 20100201 |
| Factor Xa inhibitors in acute coronary syndromes and venous thromboembolism. | Current vascular pharmacology 20100101 |
| Anticoagulation with argatroban in a parturient with heparin-induced thrombocytopenia. | International journal of obstetric anesthesia 20100101 |
| Development of a colorimetric assay for heparanase activity suitable for kinetic analysis and inhibitor screening. | Analytical biochemistry 20100101 |
| Relationship between baseline haemoglobin and major bleeding complications in acute coronary syndromes. | European heart journal 20100101 |
| Unusual onset of venous thromboembolism and heparin-induced thrombocytopenia in a patient with essential thrombocythemia. | Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 20100101 |
| A comparison of three fibrinolytic agents in prevention of intra-abdominal adhesions. | Acta chirurgica Belgica 20100101 |
| Heparin-induced thrombocytopenia in a patient treated with fondaparinux. | Clinical advances in hematology & oncology : H&O 20100101 |
| Heparin-induced thrombocytopenia associated with fondaparinux. | Clinical advances in hematology & oncology : H&O 20100101 |
| Fondaparinux and acute coronary syndromes: update on the OASIS 5-6 studies. | Vascular health and risk management 20100101 |
| Fondaparinux: a pharmacoeconomic review of its use in the management of non-ST-segment elevation acute coronary syndrome. | PharmacoEconomics 20100101 |
| [Update on current care guidelines: venous thrombosis and pulmonary embolism]. | Duodecim; laaketieteellinen aikakauskirja 20100101 |
| Heparin-induced thrombocytopenia and cerebral venous thrombosis after low-molecular weight heparin. | Neurology India 20100101 |
| Cost effectiveness of venous thromboembolism pharmacological prophylaxis in total hip and knee replacement: a systematic review. | PharmacoEconomics 20100101 |
| Managing bleeding complications in patients treated with the old and the new anticoagulants. | Current pharmaceutical design 20100101 |
| The 'chest pain kit' study: A 'pill in the pocket' concept to improve the pre-hospital therapy of acute coronary syndrome. | Cardiology journal 20100101 |
| Fondaparinux in acute coronary syndromes. | Expert opinion on drug metabolism & toxicology 20091201 |
| Therapeutic use of heparin beyond anticoagulation. | Current drug discovery technologies 20091201 |
| Thromboprophylaxis and heparin-induced thrombocytopenia. | British journal of hospital medicine (London, England : 2005) 20091201 |
| The case for venous thromboembolism prophylaxis in Africa. | East African medical journal 20091201 |
| Major bleeding, mortality, and efficacy of fondaparinux in venous thromboembolism prevention trials. | Circulation 20091117 |
| Coagulation factor Xa activates thrombin in ischemic neural tissue. | Journal of neurochemistry 20091101 |
| Favorable coagulation profile with fondaparinux after hip surgery in elderly patients. | International journal of hematology 20091101 |
| Fondaparinux for prevention of venous thromboembolism in high-risk trauma patients: a pilot study. | Journal of the American College of Surgeons 20091101 |
| From heparin to EP217609: the long way to a new pentasaccharide-based neutralisable anticoagulant with an unprecedented pharmacological profile. | Thrombosis and haemostasis 20091101 |
| Development of idraparinux and idrabiotaparinux for anticoagulant therapy. | Thrombosis and haemostasis 20091101 |
| Binding between heparin and the integrin VLA-4. | Thrombosis and haemostasis 20091101 |
| Heptest-STAT, a new assay for monitoring of low-molecular-weight heparins, is not influenced by pregnancy-related changes of blood plasma. | Thrombosis and haemostasis 20091101 |
| Thromboprophylaxis after multiple trauma: what treatment and for how long? | Injury 20091101 |
| [Pregnancy and venous thromboembolism. North-American and European guidelines. American College of Chest Physicians]. | Journal des maladies vasculaires 20091101 |
| Safety and efficacy of fondaparinux as an adjunctive treatment to thrombolysis in patients with high and intermediate risk pulmonary embolism. | Journal of thrombosis and thrombolysis 20091001 |
| A retrospective analysis of fondaparinux versus enoxaparin treatment in women with infertility or pregnancy loss. | American journal of reproductive immunology (New York, N.Y. : 1989) 20091001 |
| Fondaparinux and the management of heparin-induced thrombocytopenia: the journey continues. | The Annals of pharmacotherapy 20091001 |
| Automated assay for fondaparinux (Arixtra) on the Dade Behring BCS XP. | American journal of clinical pathology 20091001 |
| A new era for anticoagulants. | European journal of internal medicine 20091001 |
| Heparin induced thrombocytopenia and re-thrombosis associated with warfarin and fondaparinux in a child. | Pediatric blood & cancer 20090901 |
| Perioperative anticoagulant management. | The Medical clinics of North America 20090901 |
| The benefit of sample pretreatment and use of MS(10) on the Orbitrap for the analysis of pentasaccharides. | Rapid communications in mass spectrometry : RCM 20090901 |
| The reduced anticoagulant effect of fondaparinux at low antithrombin levels. | Anesthesia and analgesia 20090901 |
| Prospective randomized controlled trial on the effect of fondaparinux sodium for prevention of venous thromboembolism after hip fracture surgery. | Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association 20090901 |
| Dabigatran etexilate for the prevention of venous thromboembolism in patients undergoing elective hip and knee surgery: a single technology appraisal. | Health technology assessment (Winchester, England) 20090901 |
| Efficacy and safety of fondaparinux versus enoxaparin in patients with acute coronary syndromes treated with glycoprotein IIb/IIIa inhibitors or thienopyridines: results from the OASIS 5 (Fifth Organization to Assess Strategies in Ischemic Syndromes) trial. | Journal of the American College of Cardiology 20090728 |
| New antithrombotic agents in acute coronary syndromes. | Current opinion in cardiology 20090701 |
| Fondaparinux and epidural anaesthesia. | International journal of obstetric anesthesia 20090701 |
| Epidural labor analgesia in a patient receiving fondaparinux. | International journal of obstetric anesthesia 20090701 |
| Expert consensus on treatment strategies in non- ST-segment elevation acute coronary syndromes in patients undergoing percutaneous coronary intervention--an evidence-based review of clinical trial results and treatment guidelines from an emergency medicine perspective: report on a roundtable discussion. | The American journal of emergency medicine 20090701 |
| Prescription of fondaparinux in hospitalised patients. | Thrombosis and haemostasis 20090601 |
| Hospitals with and without percutaneous coronary intervention capability: considerations for treating acute coronary syndromes. | The American journal of emergency medicine 20090601 |
| Fondaparinux: an overview. | Expert review of cardiovascular therapy 20090601 |
| Economic and clinical evaluation of fondaparinux vs. enoxaparin for thromboprophylaxis following general surgery. | Current medical research and opinion 20090501 |
| Fondaparinux versus Enoxaparin in non-ST-elevation acute coronary syndromes: short-term cost and long-term cost-effectiveness using data from the Fifth Organization to Assess Strategies in Acute Ischemic Syndromes Investigators (OASIS-5) trial. | American heart journal 20090501 |
| Treatment of venous thromboembolism in patients with cancer: subgroup analysis of the Matisse clinical trials. | Thrombosis and haemostasis 20090401 |
| Improving clinical outcomes by reducing bleeding in patients with non-ST-elevation acute coronary syndromes. | European heart journal 20090301 |
| Reversal of the inhibitory effect of fondaparinux on thrombin generation by rFVIIa, aPCC and PCC. | Thrombosis research 20090301 |
| The pain and the gain of treating patients with acute coronary syndromes-can the two be separated? | American heart journal 20090301 |
| Fondaparinux compared to enoxaparin in patients with acute coronary syndromes without ST-segment elevation: outcomes and treatment effect across different levels of risk. | American heart journal 20090301 |
| Guideline update. VTE disease: which agents, and when. | The Journal of family practice 20090301 |
| Fondaparinux in the treatment of acute coronary syndromes: evidence from OASIS 5 and 6. | Expert review of cardiovascular therapy 20090301 |
| Pharmacokinetic and clinical data supporting the use of fondaparinux 1.5 mg once daily in the prevention of venous thromboembolism in renally impaired patients. | Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 20090301 |
| [Advances in antithrombotic treatment--antithrombotics with anti-Xa effect]. | Vnitrni lekarstvi 20090301 |
| Dutch orthopedic thromboprophylaxis: a 5-year follow-up survey. | Acta orthopaedica 20090226 |
| Do we really need an interval between administering fondaparinux and removing a lumbar plexus catheter? | Anesthesia and analgesia 20090201 |
| Heparin-induced thrombocytopenia: what clinicians need to know. | Thrombosis and haemostasis 20090201 |
| Laboratory monitoring of anticoagulation: where do we stand? | Seminars in thrombosis and hemostasis 20090201 |
| Avoiding and managing bleeding complications in patients with non-ST-segment elevation acute coronary syndromes. | Angiology 20090101 |
| Epidural labor analgesia in a patient receiving fondaparinux. | International journal of obstetric anesthesia 20090101 |
| [Prevention of deep vein thrombosis in surgical and non-surgical patients]. | Hamostaseologie 20090101 |
| Fondaparinux: a different weapon in the war on clot: update for the clinical nurse specialist. | Clinical nurse specialist CNS 20090101 |
| Heparin-induced thrombocytopenia successfully treated with fondaparinux. | Acta clinica Belgica 20090101 |
| Tissue factor and factor v involvement in rat peritoneal fibrosis. | Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis 20090101 |
| Cost effectiveness of fondaparinux in non-ST-elevation acute coronary syndrome. | PharmacoEconomics 20090101 |
| [From old to new anticoagulants: the role of the biologist]. | Annales de biologie clinique 20090101 |
| Heparin-induced thrombocytopenia: when a low platelet count is a mandate for anticoagulation. | Hematology. American Society of Hematology. Education Program 20090101 |
| Thrombocytopenia and thrombosis in disseminated intravascular coagulation (DIC). | Hematology. American Society of Hematology. Education Program 20090101 |
| Prevention and treatment of thromboembolic events in medical patients and new anticoagulants. | Acta clinica Belgica 20090101 |
| Budd-Chiari syndrome and heparin-induced thrombocytopenia in polycythemia vera: successful treatment with repeated TIPS and interferon alpha. | Journal of cancer research and therapeutics 20090101 |
| Delayed-onset heparin-induced thrombocytopenia type-2 during fondiparinux (Arixtra) therapy. | Proceedings of the Western Pharmacology Society 20090101 |
| Bias in AJHP supplements. | American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20081215 |
| Heparin-induced thrombocytopenia--therapeutic concentrations of danaparoid, unlike fondaparinux and direct thrombin inhibitors, inhibit formation of platelet factor 4-heparin complexes. | Journal of thrombosis and haemostasis : JTH 20081201 |
| Postinjury thromboprophylaxis. | Current opinion in critical care 20081201 |
| [Pharmacology of heparins and direct anticoagulants]. | Hamostaseologie 20081201 |
| [Heparin-induced thrombocythopenia in a patient with massive pulmonary embolism and dilated cardiomyopathy, successfuly treated with fondaparinux - a case report]. | Kardiologia polska 20081201 |
| [Perioperative venous thromboembolism prophylaxis: short review and recommendations]. | Annales francaises d'anesthesie et de reanimation 20081201 |
| Antithrombotic therapy with fondaparinux in relation to interventional management strategy in patients with ST- and non-ST-segment elevation acute coronary syndromes: an individual patient-level combined analysis of the Fifth and Sixth Organization to Assess Strategies in Ischemic Syndromes (OASIS 5 and 6) randomized trials. | Circulation 20081111 |
| Delayed-onset HIT caused by low-molecular-weight heparin manifesting during fondaparinux prophylaxis. | American journal of hematology 20081101 |
| The use of graduated compression stockings in association with fondaparinux in surgery of the hip: a multicentre, multinational, randomised, open-label, parallel-group comparative study. | The Journal of bone and joint surgery. British volume 20081101 |
| The synthetic pentasaccharide fondaparinux prevents coronary microvascular injury and myocardial dysfunction in the ischemic heart. | Thrombosis and haemostasis 20081101 |
| [Venous thromboembolism and immobilization for medical reason]. | Medicina clinica 20081101 |
| [Anaesthesia and thromboembolic disease]. | Medicina clinica 20081101 |
| Cost and occurrence of thrombocytopenia in patients receiving venous thromboembolism prophylaxis following major orthopaedic surgeries. | Journal of thrombosis and thrombolysis 20081001 |
| Rivaroxaban--an oral, direct Factor Xa inhibitor--has potential for the management of patients with heparin-induced thrombocytopenia. | British journal of haematology 20081001 |
| Recombinant activated factor VII for acute subdural haematoma in an elderly patient taking fondaparinux. | British journal of anaesthesia 20081001 |
| Prevention of venous thromboembolism in hospitalized medical patients. | The Mount Sinai journal of medicine, New York 20081001 |
| New anticoagulants. | Current opinion in hematology 20080901 |
| Prothrombinase-induced clotting time assay for determination of the anticoagulant effects of unfractionated and low-molecular-weight heparins, fondaparinux, and thrombin inhibitors. | American journal of clinical pathology 20080901 |
| Venous thromboembolism clinically detected after hip fracture surgery with prophylaxis in a clinical practice setting. | American journal of orthopedics (Belle Mead, N.J.) 20080901 |
| Fondaparinux prevents venous thromboembolism after joint replacement surgery in Japanese patients. | International orthopaedics 20080801 |
| Potent anticoagulants are associated with a higher all-cause mortality rate after hip and knee arthroplasty. | Clinical orthopaedics and related research 20080801 |
| Thrombin generation assays are superior to traditional tests in assessing anticoagulation reversal in vitro. | Thrombosis and haemostasis 20080801 |
| Cerebral venous thrombosis and heparin-induced thrombocytopenia in an 18-year old male with severe ulcerative colitis. | World journal of gastroenterology 20080728 |
| 2007 Guideline update for unstable angina/non-ST-segment elevation myocardial infarction: focus on antiplatelet and anticoagulant therapies. | The Annals of pharmacotherapy 20080701 |
| Which heparin and how much? | Current cardiology reports 20080701 |
| Fondaparinux-related thrombocytopenia in a patient with former HIT. Response to Rota et al. (Thromb Haemost 2008; 99: 779-781). | Thrombosis and haemostasis 20080701 |
| VTE prevention in major orthopedic surgery. | Cleveland Clinic journal of medicine 20080701 |
| VTE prevention in major orthopedic surgery. | Cleveland Clinic journal of medicine 20080701 |
| Can heparin-induced thrombocytopenia be associated with fondaparinux use? A rebuttal. | Journal of thrombosis and haemostasis : JTH 20080701 |
| Electrochemical recognition of synthetic heparin mimetic at liquid/liquid microinterfaces. | Journal of the American Chemical Society 20080611 |
| In-vitro comparison of fondaparinux, unfractionated heparin, and enoxaparin in preventing cardiac catheter-associated thrombus. | Coronary artery disease 20080601 |
| Parenteral anticoagulants: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). | Chest 20080601 |
| Hemorrhagic complications of anticoagulant and thrombolytic treatment: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). | Chest 20080601 |
| Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). | Chest 20080601 |
| Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). | Chest 20080601 |
| Antithrombotic therapy for non-ST-segment elevation acute coronary syndromes: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). | Chest 20080601 |
| The use of fondaparinux for the treatment of venous thromboembolism in a patient with heparin-induced thombocytopenia and thrombosis caused by heparin flushes. | Therapeutics and clinical risk management 20080601 |
| Successful use of fondaparinux as an alternative anticoagulant in a 2-month-old infant. | Pediatric blood & cancer 20080501 |
| Heparins, low-molecular-weight heparins, and pentasaccharides: use in the older patient. | Cardiology clinics 20080501 |
| Prevention of venous thromboembolism in the geriatric patient. | Cardiology clinics 20080501 |
| Anticoagulant treatment of deep vein thrombosis and pulmonary embolism. | Cardiology clinics 20080501 |
| The effect of anticoagulant pharmacotherapy on fracture healing. | Expert opinion on pharmacotherapy 20080501 |
| Initial management of deep venous thrombosis in the outpatient setting. | American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20080501 |
| Heparin-induced thrombocytopenia: a review of current pharmacologic treatment. | Connecticut medicine 20080501 |
| Detection of surface bound complement at increasing serum anticoagulant concentrations. | Colloids and surfaces. B, Biointerfaces 20080401 |
| Fondaparinux in patients with impaired renal function: the right choice? | Annals of internal medicine 20080401 |
| Post-thrombotic syndrome in children: a single center experience. | Journal of pediatric hematology/oncology 20080401 |
| Fondaparinux-related thrombocytopenia in a previous low-molecular-weight heparin (LMWH)-induced heparin-induced thrombocytopenia (HIT). | Thrombosis and haemostasis 20080401 |
| Fondaparinux for the prevention or treatment of venous thromboembolism related to lower limb trauma: evidence today. | Current vascular pharmacology 20080401 |
| Use of fondaparinux as an anticoagulant during hemodialysis: a preliminary study. | International journal of clinical pharmacology and therapeutics 20080401 |
| [Heparin induced thrombocytopenia and anticoagulation in renal replacemant therapy]. | Anasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS 20080401 |
| Prevention of venous thromboembolism in the orthopedic surgery patient. | Cleveland Clinic journal of medicine 20080401 |
| Venous thromboembolism (VTE). | Cleveland Clinic journal of medicine 20080401 |
| Prevention of venous thromboembolism in the cancer surgery patient. | Cleveland Clinic journal of medicine 20080401 |
| New anticoagulant strategies in ST elevation myocardial infarction: trials and clinical implications. | Vascular health and risk management 20080401 |
| [Fondaparinux: the present and the future]. | Pathologie-biologie 20080301 |
| Potent anticoagulants are associated with a higher all-cause mortality rate after hip and knee arthroplasty. | Clinical orthopaedics and related research 20080301 |
| Tolerance of fondaparinux in patients with generalized contact dermatitis to heparin. | Journal of the European Academy of Dermatology and Venereology : JEADV 20080301 |
| Standardizing the management of heparin-induced thrombocytopenia. | American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20080215 |
| Effects of fondaparinux in patients with ST-segment elevation acute myocardial infarction not receiving reperfusion treatment. | European heart journal 20080201 |
| The role of fondaparinux as an adjunct to thrombolytic therapy in acute myocardial infarction: a subgroup analysis of the OASIS-6 trial. | European heart journal 20080201 |
| [New anticoagulants]. | Hamostaseologie 20080201 |
| Recent developments in acute coronary syndromes. | Clinical medicine (London, England) 20080201 |
| Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer. | The Cochrane database of systematic reviews 20080123 |
| Fondaparinux: use in thromboprophylaxis of acute medical patients. | Drugs & aging 20080101 |
| Fondaparinux versus direct thrombin inhibitor therapy for the management of heparin-induced thrombocytopenia (HIT)--bridging the River Coumarin. | Thrombosis and haemostasis 20080101 |
| Fondaparinux for the treatment of patients with acute heparin-induced thrombocytopenia. | Thrombosis and haemostasis 20080101 |
| Heparin-induced thrombocytopenia: a stoichiometry-based model to explain the differing immunogenicities of unfractionated heparin, low-molecular-weight heparin, and fondaparinux in different clinical settings. | Thrombosis research 20080101 |
| Citrate anticoagulation protocol for slow extended hemodialysis with the Genius dialysis system in acute renal failure. | The International journal of artificial organs 20080101 |
| Primary prophylaxis of venous thromboembolism in surgical patients. | Vascular and endovascular surgery 20080101 |
| The in vitro anticoagulant effects of danaparoid, fondaparinux, and lepirudin in children compared to adults. | Thrombosis research 20080101 |
| Fondaparinux sodium: a review of its use in the management of acute coronary syndromes. | American journal of cardiovascular drugs : drugs, devices, and other interventions 20080101 |
| Factor Xa inactivation in acute coronary syndrome. | Current pharmaceutical design 20080101 |
| Monitoring direct FXa-inhibitors and fondaparinux by Prothrombinase-induced Clotting Time (PiCT): relation to FXa-activity and influence of assay modifications. | Thrombosis research 20080101 |
| Parenteral anticoagulation may prolong the survival of patients with limited small cell lung cancer: a Cochrane systematic review. | Journal of experimental & clinical cancer research : CR 20080101 |
| [Guidelines for prevention of venous thromboembolism in Austria]. | Wiener klinische Wochenschrift 20080101 |
| [Novel anticoagulant fondaparinux in the treatment of acute coronary syndrome]. | Kardiologiia 20080101 |
| Spotlight on fondaparinux sodium in acute coronary syndromes. | BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 20080101 |
| New anticoagulants in children. | Hematology. American Society of Hematology. Education Program 20080101 |
| [Fondaparinux and invasive treatment of non-ST elevation acute coronary syndrome]. | Kardiologiia 20080101 |
| Heparin-induced thrombocytopenia and phlegmasia cerulea dolens of the upper limb successfully treated with fondaparinux. | Acta haematologica 20080101 |
| [Venous thromboembolism prophylaxis in major orthopaedic surgery: A multicenter, prospective, observational study]. | Acta orthopaedica et traumatologica turcica 20080101 |
| Cost-effectiveness of extended prophylaxis with fondaparinux compared with low molecular weight heparin against venous thromboembolism in patients undergoing hip fracture surgery. | The European journal of health economics : HEPAC : health economics in prevention and care 20071201 |
| Inhibition of thrombin generation in recalcified plasma. | Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 20071201 |
| The safety and efficacy of extended thromboprophylaxis with fondaparinux after major orthopedic surgery of the lower limb with or without a neuraxial or deep peripheral nerve catheter: the EXPERT Study. | Anesthesia and analgesia 20071201 |
| Use of the pentasaccharide fondaparinux as an anticoagulant during haemodialysis. | Thrombosis and haemostasis 20071201 |
| Once-daily fondaparinux monotherapy without warfarin for long-term treatment of venous thromboembolism. | Thrombosis and haemostasis 20071201 |
| Fondaparinux as an alternative therapy in heparin-induced delayed-type hypersensitivity skin lesions. | Thrombosis and haemostasis 20071201 |
| Delayed hypersensitivity to low-molecular-weight heparin (LMWH) in pregnancy. | South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde 20071201 |
| Comparison of cost, effectiveness, and safety of injectable anticoagulants used for thromboprophylaxis after orthopedic surgery. | American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20071115 |
| Efficacy and safety of fondaparinux in patients with acute coronary syndromes. | Expert review of cardiovascular therapy 20071101 |
| Nonbleeding complications of unfractionated and low-molecular weight heparins. | Clinical advances in hematology & oncology : H&O 20071101 |
| Efficacy and safety of fondaparinux versus enoxaparin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: results from the OASIS-5 trial. | Journal of the American College of Cardiology 20071030 |
| Monitoring fondaparinux with the Sonoclot. | Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 20071001 |
| The pharmacoeconomics of deep vein thrombosis treatment. | The American journal of medicine 20071001 |
| [Heparin-induced thrombocytopenia]. | Revista espanola de cardiologia 20071001 |
| [Optimizing antithrombotic therapy in non-ST-elevation acute coronary syndrome]. | Revista espanola de cardiologia 20071001 |
| The Editor's Roundtable: arterial thrombosis and acute coronary syndromes. | The American journal of cardiology 20070915 |
| Influence of renal function on the efficacy and safety of fondaparinux relative to enoxaparin in non ST-segment elevation acute coronary syndromes. | Annals of internal medicine 20070904 |
| The prophylaxis of venous thrombosis in patients with cancer undergoing major abdominal surgery: emerging options. | Journal of surgical oncology 20070901 |
| Fondaparinux combined with intermittent pneumatic compression vs. intermittent pneumatic compression alone for prevention of venous thromboembolism after abdominal surgery: a randomized, double-blind comparison. | Journal of thrombosis and haemostasis : JTH 20070901 |
| Extended travel after hip arthroplasty surgery. Is it safe? | The Journal of arthroplasty 20070901 |
| Percutaneous coronary interventions in patients with heparin-induced thrombocytopenia. | Current cardiology reports 20070901 |
| [Heparin-induced thrombocytopenia: a brief update in an Italian perspective]. | Recenti progressi in medicina 20070901 |
| Treatment of thrombosis with fondaparinux (Arixtra) in a patient with end-stage renal disease receiving hemodialysis therapy. | Journal of pediatric hematology/oncology 20070801 |
| Beyond unfractionated heparin and warfarin: current and future advances. | Circulation 20070731 |
| Prophylaxis for thromboembolism in hospitalized medical patients. | The New England journal of medicine 20070719 |
| New anticoagulant options for ST-elevation myocardial infarction and unstable angina pectoris/non-ST-elevation myocardial infarction. | Current cardiology reports 20070701 |
| Enzymatic synthesis of glycosaminoglycan heparin. | Seminars in thrombosis and hemostasis 20070701 |
| Determination of antithrombin-dependent factor Xa inhibitors by prothrombin-induced clotting time. | Seminars in thrombosis and hemostasis 20070701 |
| The use of graduated compression stockings in association with fondaparinux in surgery of the hip. A multicentre, multinational, randomised, open-label, parallel-group comparative study. | The Journal of bone and joint surgery. British volume 20070701 |
| Heparin-induced thrombocytopenia associated with fondaparinux. | The New England journal of medicine 20070621 |
| Minimizing costs for treating deep vein thrombosis: the role for fondaparinux. | Journal of thrombosis and thrombolysis 20070601 |
| Effect of obesity on outcomes after fondaparinux, enoxaparin, or heparin treatment for acute venous thromboembolism in the Matisse trials. | Journal of thrombosis and haemostasis : JTH 20070601 |
| Assessing, preventing, and treating venous thromboembolism: evidence-based approaches. | American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20070601 |
| Fondaparinux as a treatment option for heparin-induced thrombocytopenia. | Pharmacotherapy 20070601 |
| [Standards and perspectives for thromboembolism prophylaxis]. | Der Orthopade 20070601 |
| Bioengineering novel in vitro metabolic pathways using synthetic biology. | Current opinion in microbiology 20070601 |
| [Fondaparinux in the treatment of pulmonary thromboembolism: MATISSE study]. | Revista clinica espanola 20070601 |
| Management of acute coronary syndromes with fondaparinux. | Vascular health and risk management 20070601 |
| Prevention and treatment of venous thromboembolism in the elderly patient. | Clinical interventions in aging 20070601 |
| [Initial treatment of venous thromboembolic events]. | La Revue du praticien 20070415 |
| Clinical practice. Prophylaxis for thromboembolism in hospitalized medical patients. | The New England journal of medicine 20070405 |
| Fondaparinux: pharmacology and clinical experience in cardiovascular medicine. | Mini reviews in medicinal chemistry 20070401 |
| Monitoring effects of direct FXa-inhibitors with a new one-step prothrombinase-induced clotting time (PiCT) assay: comparative in vitro investigation with heparin, enoxaparin, fondaparinux and DX 9065a. | International journal of clinical pharmacology and therapeutics 20070401 |
| High affinity interaction between a synthetic, highly negatively charged pentasaccharide and alpha- or beta-antithrombin is predominantly due to nonionic interactions. | Biochemistry 20070320 |
| Differential effects of direct thrombin inhibitors and antithrombin-dependent anticoagulants on the dynamics of clot formation. | Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 20070301 |
| Prevention and treatment of experimental thrombosis in rabbits with rivaroxaban (BAY 597939)--an oral, direct factor Xa inhibitor. | Thrombosis and haemostasis 20070301 |
| Fondaparinux is an effective alternative anticoagulant in pregnant women with high risk of venous thromboembolism and intolerance to low-molecular-weight heparins and heparinoids. | Thrombosis and haemostasis 20070301 |
| Perioperative bridging with fondaparinux in a woman with antithrombin deficiency. | Thrombosis and haemostasis 20070301 |
| Low-dose fondaparinux in suspected heparin-induced thrombocytopenia in the critically ill. | The Netherlands journal of medicine 20070301 |
| [Fondaparinux--evolution or revolution in anticoagulant care?]. | Polskie Archiwum Medycyny Wewnetrznej 20070301 |
| New anticoagulants: from bench to bedside. | Hamostaseologie 20070201 |
| American Society of Hematology--48th Annual Meeting and Exposition. The Factor Xa target, and disorders of platelet number and function. 9-12 December 2006 Orlando, FL, USA. | IDrugs : the investigational drugs journal 20070201 |
| Coagulation factor Xa modulates airway remodeling in a murine model of asthma. | American journal of respiratory and critical care medicine 20070115 |
| Treatment of a woman with lupus and thromboembolism and cutaneous intolerance to heparins using fondaparinux during pregnancy. | Thrombosis research 20070101 |
| Effect of substrate and fibrin polymerization inhibitor on determination of plasma thrombin generation in vitro. | Thrombosis research 20070101 |
| Clot structure modification by fondaparinux and consequence on fibrinolysis: a new mechanism of antithrombotic activity. | Thrombosis and haemostasis 20070101 |
| Fondaparinux in the management of recurrent venous thromboembolic events in a patient with active lung cancer. | Thrombosis research 20070101 |
| Venous thromboembolism after orthopedic surgery: implications of the choice for prophylaxis. | Thrombosis research 20070101 |
| [Prevention of venous thromboembolism in orthopedic surgery and traumatology]. | Recenti progressi in medicina 20070101 |
| [Diagnosis and management of deep venous thrombosis]. | Revista de medicina de la Universidad de Navarra 20070101 |
| Heparin-induced thrombocytopenia: a general review. | Journal of infusion nursing : the official publication of the Infusion Nurses Society 20070101 |
| Retroperitoneal hematoma due to spontaneous lumbar artery rupture during fondaparinux treatment. Case report and review of the literature. | Acta bio-medica : Atenei Parmensis 20070101 |
| Anticoagulation for acute coronary syndromes: from heparin to direct thrombin inhibitors. | Reviews in cardiovascular medicine 20070101 |
| Current challenges of anticoagulant treatment. | Romanian journal of internal medicine = Revue roumaine de medecine interne 20070101 |
| [Recurrent pulmonary embolism in a patient with heparin-induced thrombocytopenia]. | Polskie Archiwum Medycyny Wewnetrznej 20070101 |
| A coagulation factor VII deficiency protects against acute inflammatory responses in mice. | The Journal of pathology 20061201 |
| A non-anticoagulant synthetic pentasaccharide reduces inflammation in a murine model of kidney ischemia-reperfusion injury. | Thrombosis and haemostasis 20061201 |
| Review of fondaparinux sodium injection for the prevention of venous thromboembolism in patients undergoing surgery. | Vascular health and risk management 20061201 |
| Fondaparinux in the management of patients with ST-elevation acute myocardial infarction. | Vascular health and risk management 20061201 |
| Thromboprophylaxis in major abdominal surgery for cancer. | European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 20061101 |
| Effect of fondaparinux on coagulation assays: results of College of American Pathologists proficiency testing. | Archives of pathology & laboratory medicine 20061101 |
| Fondaparinux in patients with ST-segment elevation myocardial infarction. | JAMA 20061101 |
| Fondaparinux in patients with ST-segment elevation myocardial infarction. | JAMA 20061101 |
| Fondaparinux in patients with ST-segment elevation myocardial infarction. | JAMA 20061101 |
| Bleeding in acute coronary syndromes. | Timely topics in medicine. Cardiovascular diseases 20061101 |
| Comparison of fondaparinux, low molecular-weight heparin and unfractionated heparin in preventing thrombus formation on mechanical heart valves: results of an in-vitro study. | The Journal of heart valve disease 20061101 |
| Prevention of venous thromboembolism. | Seminars in thrombosis and hemostasis 20061101 |
| Are placebo-controlled trials ethical in areas where current guidelines recommend therapy? No. | Journal of thrombosis and haemostasis : JTH 20061001 |
| Close approximation of two platelet factor 4 tetramers by charge neutralization forms the antigens recognized by HIT antibodies. | Arteriosclerosis, thrombosis, and vascular biology 20061001 |
| The influence of new antithrombotic drugs on regional anesthesia. | Current opinion in anaesthesiology 20061001 |
| Are placebo-controlled trials ethical in areas where current guidelines recommend therapy? Yes. | Journal of thrombosis and haemostasis : JTH 20061001 |
| Evidence for the prevention of venous thromboembolism. | British journal of nursing (Mark Allen Publishing) 20061001 |
| Fondaparinux is a safe alternative in case of heparin intolerance during pregnancy. | Blood 20060901 |
| Emerging anticoagulants for the treatment of venous thromboembolism. | Thrombosis and haemostasis 20060901 |
| Comparison of a single end point to determine optimal initial warfarin dosing (5 mg versus 10 mg) for venous thromboembolism. | The American journal of cardiology 20060815 |
| Treatment dosage recommendation for fondaparinux in a patient with heparin induced thrombocytopenia. | Journal of thrombosis and thrombolysis 20060801 |
| Novel factor Xa inhibitors for prevention and treatment of thromboembolic diseases. | Expert opinion on investigational drugs 20060801 |
| Heparin-induced thrombocytopenia and cardiovascular diseases. | American heart journal 20060701 |
| Use of fondaparinux in a patient with antiphospholipid antibody syndrome and heparin-associated thrombocytopenia. | Journal of thrombosis and haemostasis : JTH 20060701 |
| Safer alternative to heparin identified. | Health news (Waltham, Mass.) 20060701 |
| Advances in antithrombotic therapy in acute myocardial infarction: the ExTRACT-TIMI 25 and OASIS-6 Trials. | Current cardiology reports 20060701 |
| Fondaparinux versus enoxaparin in acute coronary syndromes. | The New England journal of medicine 20060629 |
| Immediate type hypersensitivity to low molecular weight heparins and tolerance of unfractioned heparin and fondaparinux. | Allergy 20060601 |
| [Deep vein thrombosis: new drugs and future therapeutic perspectives]. | Revista clinica espanola 20060601 |
| Development and clinical evaluation of two chromogenic substrate methods for monitoring fondaparinux sodium. | Therapeutic drug monitoring 20060601 |
| Argatroban dosing of patients with heparin-induced thrombocytopenia and an elevated aPTT due to antiphospholipid antibody syndrome. | The Annals of pharmacotherapy 20060501 |
| Role of current and emerging antithrombotics in thrombosis and cancer. | Drugs of today (Barcelona, Spain : 1998) 20060501 |
| NCCN issues first guidelines for deep vein thrombosis treatment in cancer patients. | Journal of the National Cancer Institute 20060419 |
| Comparison of fondaparinux and enoxaparin in acute coronary syndromes. | The New England journal of medicine 20060406 |
| Therapy for patients with acute coronary syndromes--new opportunities. | The New England journal of medicine 20060406 |
| Fondaparinux in ST-segment elevation myocardial infarction: the drug, the strategy, the environment, or all of the above? | JAMA 20060405 |
| Effects of fondaparinux on mortality and reinfarction in patients with acute ST-segment elevation myocardial infarction: the OASIS-6 randomized trial. | JAMA 20060405 |
| Potential inhibitors of chemokine function: analysis of noncovalent complexes of CC chemokine and small polyanionic molecules by ESI FT-ICR mass spectrometry. | Journal of the American Society for Mass Spectrometry 20060401 |
| [Prevention of venous thromboembolism in older acute hospitalized patients]. | Kardiologia polska 20060401 |
| Evaluation of wound healing after total knee arthroplasty in a randomized prospective trial comparing fondaparinux with enoxaparin. | The Knee 20060301 |
| The effect of different anticoagulants on thrombin generation. | Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 20060301 |
| Fondaparinux as anticoagulant in a pregnant woman with heparin allergy. | Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 20060301 |
| The effect of fondaparinux versus enoxaparin in the survival of a congested skin flap in a rabbit model. | Annals of plastic surgery 20060301 |
| Disappearance of anti-PF4/heparin antibodies under prolonged fondaparinux administration in a patient with DVT associated with LMWH-induced thrombocytopenia. | Thrombosis and haemostasis 20060301 |
| [Prevention of venous thromboembolism: generally accepted guidelines]. | Vnitrni lekarstvi 20060301 |
| [Prevention of venous thromboembolism in orthopaedics]. | Vnitrni lekarstvi 20060301 |
| Clinical trials of new anticoagulants. | Vnitrni lekarstvi 20060301 |
| New oral anticoagulants show promise. | JAMA 20060215 |
| Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial. | BMJ (Clinical research ed.) 20060211 |
| Venous thromboembolism: heparins are of porcine origin. | BMJ (Clinical research ed.) 20060211 |
| Heparins, low-molecular-weight heparins, and pentasaccharides. | Clinics in geriatric medicine 20060201 |
| Treatment of heparin-induced thrombocytopenia in cardiovascular patients. | Expert opinion on pharmacotherapy 20060201 |
| New concepts in heparin-induced thrombocytopenia: diagnosis and management. | Journal of thrombosis and thrombolysis 20060201 |
| Venous thromboembolism. | BMJ (Clinical research ed.) 20060128 |
| Factor Xa inhibitors: new anti-thrombotic agents and their characteristics. | Frontiers in bioscience : a journal and virtual library 20060101 |
| Assessment of a self-administration protocol for extended subcutaneous thromboprophylaxis in lower limb arthroplasty. | The Journal of bone and joint surgery. British volume 20060101 |
| The structures of the thrombospondin-1 N-terminal domain and its complex with a synthetic pentameric heparin. | Structure (London, England : 1993) 20060101 |
| [Patient with antithrombotic medication. Which do bleedings or preoperative?]. | Laryngo- rhino- otologie 20060101 |
| Flexibility in administration of fondaparinux for prevention of symptomatic venous thromboembolism in orthopaedic surgery. | The Journal of arthroplasty 20060101 |
| Blood thinner cuts risk of bleeding in half. | Health news (Waltham, Mass.) 20060101 |
| Cost-effectiveness of fondaparinux compared with enoxaparin as prophylaxis against venous thromboembolism in patients undergoing hip fracture surgery. | Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 20060101 |
| Anticoagulation via anti-Factor Xa inhibition. | Lupus 20060101 |
| Fondaparinux for thromboembolic treatment and prophylaxis of heparin-induced thrombocytopenia. | The Annals of pharmacotherapy 20060101 |
| Thromboprophylaxis in medical patients--why not for all? | Pathophysiology of haemostasis and thrombosis 20060101 |
| [Thrombocytopenia probably heparin-induced in women with tumor of the heart and pulmonary embolism]. | Pneumonologia i alergologia polska 20060101 |
| Anti-platelet factor 4/heparin antibodies in orthopedic surgery patients receiving antithrombotic prophylaxis with fondaparinux or enoxaparin. | Blood 20051201 |
| Design and rationale of the MICHELANGELO Organization to Assess Strategies in Acute Ischemic Syndromes (OASIS)-5 trial program evaluating fondaparinux, a synthetic factor Xa inhibitor, in patients with non-ST-segment elevation acute coronary syndromes. | American heart journal 20051201 |
| Development of antibodies specific to polyanion-modified platelet factor 4 during treatment with fondaparinux. | Journal of thrombosis and haemostasis : JTH 20051201 |
| Molecular weight determines the frequency of delayed type hypersensitivity reactions to heparin and synthetic oligosaccharides. | Thrombosis and haemostasis 20051201 |
| New anticoagulants for venous thromboembolic disease. | Current opinion in cardiology 20051101 |
| [Is there a difference between low-molecular-weight heparins?]. | Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke 20051020 |
| Randomized clinical trial of postoperative fondaparinux versus perioperative dalteparin for prevention of venous thromboembolism in high-risk abdominal surgery. | The British journal of surgery 20051001 |
| A postal survey of current thromboprophylactic practices of consultant orthopaedic surgeons in the treatment of fracture of the hip. | The Journal of bone and joint surgery. British volume 20051001 |
| Differential metastasis inhibition by clinically relevant levels of heparins--correlation with selectin inhibition, not antithrombotic activity. | Clinical cancer research : an official journal of the American Association for Cancer Research 20051001 |
| Hypersensitivity to the pentasaccharide fondaparinux in patients with delayed-type heparin allergy. | Thrombosis and haemostasis 20051001 |
| Homonymous hemianopia caused by occipital lobe infarction in heparin-induced thrombocytopenia and thrombosis syndrome. | Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society 20050901 |
| Heparin and other rapidly acting anticoagulants. | Seminars in vascular surgery 20050901 |
| [Thrombosis prophylaxis and rational pharmacotherapy]. | Ugeskrift for laeger 20050815 |
| New antithrombotics in the prevention of thromboembolic disease. | European journal of internal medicine 20050801 |
| Fondaparinux: a potential new therapy for HIT. | Hematology (Amsterdam, Netherlands) 20050801 |
| Emerging strategies in the prevention of venous thromboembolism in hospitalized medical patients. | Chest 20050801 |
| [Monitoring anticoagulation by fondaparinux: determination of anti factor Xa-level]. | Hamostaseologie 20050801 |
| Ximelagatran for the prevention of venous thromboembolism following elective hip or knee replacement surgery. | Seminars in vascular medicine 20050801 |
| Treating patients with venous thromboembolism: initial strategies and long-term secondary prevention. | Seminars in vascular medicine 20050801 |
| [Primary prevention of deep vein thrombosis in non-surgical patients]. | Deutsche medizinische Wochenschrift (1946) 20050715 |
| The safety of fondaparinux for the prevention and treatment of venous thromboembolism. | Expert opinion on drug safety 20050701 |
| Short- and long-acting synthetic pentasaccharides as antithrombotic agents. | Expert opinion on investigational drugs 20050701 |
| [Thromboprophylaxis in hip and knee arthroplasty. Are the new anticoagulants better than those previously used?]. | Ugeskrift for laeger 20050523 |
| [The cost-effectiveness of fondaparinux compared to enoxaparin as prophylaxis for deep-vein thrombosis in Denmark]. | Ugeskrift for laeger 20050523 |
| Successful treatment of heparin induced thrombocytopenia (HIT) with fondaparinux. | Thrombosis and haemostasis 20050501 |
| Minimising the risk of heparin-induced osteoporosis during pregnancy. | Expert opinion on drug safety 20050501 |
| Optimizing antiplatelet and anticoagulant agents in the perioperative orthopedic surgery patient. | Orthopedics 20050501 |
| Treatment of postoperative bleeding after fondaparinux with rFVIIa and tranexamic acid. | The Netherlands journal of medicine 20050501 |
| Effects of anticoagulant treatment on intestinal ischaemia and reperfusion injury in rats. | Acta anaesthesiologica Scandinavica 20050401 |
| [Innovation instead of imitation -- news in drug therapy]. | Deutsche medizinische Wochenschrift (1946) 20050401 |
| Current and emerging options in the management of venous thromboembolism. | Cleveland Clinic journal of medicine 20050401 |
| Cost considerations surrounding current and future anticoagulant therapies. | Cleveland Clinic journal of medicine 20050401 |
| [Prophylaxis and treatment of venous thromboembolism: the role of new antithrombotic drugs]. | Recenti progressi in medicina 20050401 |
| Randomized, blinded trial comparing fondaparinux with unfractionated heparin in patients undergoing contemporary percutaneous coronary intervention: Arixtra Study in Percutaneous Coronary Intervention: a Randomized Evaluation (ASPIRE) Pilot Trial. | Circulation 20050322 |
| Unexpected delayed-type hypersensitivity skin reactions to the ultra-low-molecular-weight heparin fondaparinux. | Allergy 20050301 |
| From heparins to factor Xa inhibitors and beyond. | European journal of clinical investigation 20050301 |
| Rationale for the use of antifactor Xa in the treatment and prevention of venous and arterial thromboembolic events. | European journal of clinical investigation 20050301 |
| Fondaparinux: an update on new study results. | European journal of clinical investigation 20050301 |
| The 'precautionary principle' as a guide for future drug development. | European journal of clinical investigation 20050301 |
| The synthetic pentasaccharide fondaparinux reduces coagulation, inflammation and neutrophil accumulation in kidney ischemia-reperfusion injury. | Journal of thrombosis and haemostasis : JTH 20050301 |
| New anticoagulants for the prevention and treatment of venous thromboembolism. | Vascular health and risk management 20050301 |
| Effect of low molecular weight heparin (dalteparin) and fondaparinux (Arixtra) on human osteoblasts in vitro. | The British journal of surgery 20050201 |
| Unfractionated heparin, low molecular weight heparins, and pentasaccharide: basic mechanism of actions, pharmacology, and clinical use. | Hematology/oncology clinics of North America 20050201 |
| Use of fondaparinux (ARIXTRA) in a dialysis patient with symptomatic heparin-induced thrombocytopaenia type II. | Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 20050201 |
| The management of patients with heparin-induced thrombocytopenia who require anticoagulant therapy. | Chest 20050201 |
| New ways to prevent venous thromboembolism--the pentasaccharide fondaparinux and the thrombin inhibitor ximelagatran--a review. | Acta chirurgica Belgica 20050201 |
| Effect of fondaparinux on platelet activation in the presence of heparin-dependent antibodies: a blinded comparative multicenter study with unfractionated heparin. | Blood 20050101 |
| Thrombin-directed inhibitors: pharmacology and clinical use. | American heart journal 20050101 |
| Extended anticoagulation therapy for the primary and secondary prevention of venous thromboembolism. | Drugs 20050101 |
| [Fondaparinux--a good therapeutic alternative. Interesting pharmacological action for thrombosis prevention in orthopedic surgery]. | Lakartidningen 20050101 |
| Fondaparinux sodium compared with enoxaparin sodium: a cost-effectiveness analysis. | American journal of cardiovascular drugs : drugs, devices, and other interventions 20050101 |
| Fondaparinux. | Current pharmaceutical design 20050101 |
| The treatment of deep venous thrombosis, including the newer agents. | Disease-a-month : DM 20050101 |
| Management of pulmonary embolism in 2005. | Disease-a-month : DM 20050101 |
| Severe thrombocytopenia after heparin therapy in a patient with unstable angina and recent stent implantation. | Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese 20050101 |
| Inhibition of Factor Xa : a potential target for the development of new anticoagulants. | American journal of cardiovascular drugs : drugs, devices, and other interventions 20050101 |
| Anticoagulant use in patients with chronic renal impairment. | American journal of cardiovascular drugs : drugs, devices, and other interventions 20050101 |
| Fondaparinux sodium: a review of its use in the treatment of acute venous thromboembolism. | American journal of cardiovascular drugs : drugs, devices, and other interventions 20050101 |
| [Novel possibilities of antithrombotic therapy in patients with chronic heart failure]. | Kardiologiia 20050101 |
| [New antithrombotic drugs: fondaparinux, idraparinux, ximelagatran]. | Przeglad lekarski 20050101 |
| Clinical trials of deep vein thrombosis prophylaxis in medical patients. | Clinical cornerstone 20050101 |
| [New anticoagulants in clinical practice]. | Orvosi hetilap 20041205 |
| In vitro comparison of the effect of fondaparinux and enoxaparin on whole blood tissue factor-triggered thromboelastography profile. | Thrombosis and haemostasis 20041201 |
| Economic considerations in the prevention and treatment of venous thromboembolism. | American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20041201 |
| Advances in anticoagulation therapy: the role of selective inhibitors of factor Xa and thrombin in thromboprophylaxis after major orthopedic surgery. | Seminars in thrombosis and hemostasis 20041201 |
| Accelerating ability of synthetic oligosaccharides on antithrombin inhibition of proteinases of the clotting and fibrinolytic systems. Comparison with heparin and low-molecular-weight heparin. | Thrombosis and haemostasis 20041101 |
| Cardiology patient pages. Prevention of deep vein thrombosis and pulmonary embolism. | Circulation 20041019 |
| Novel antithrombotic agents: indirect synthetic inhibitors of factor Xa and direct thrombin inhibitors. Evidences from clinical studies. | Current medicinal chemistry. Cardiovascular and hematological agents 20041001 |
| Effects of pentasaccharide (fondaparinux) and direct thrombin inhibitors on coagulation testing. | Archives of pathology & laboratory medicine 20041001 |
| Cost analysis of fondaparinux versus enoxaparin as venous thromboembolism prophylaxis in elective hip replacement surgery. | Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 20041001 |
| Efficacy of fondaparinux for thromboprophylaxis in hip fracture patients. | The Journal of arthroplasty 20041001 |
| Preparing for the post-warfarin generation of antithrombotics. | The American journal of managed care 20041001 |
| Pentasaccharides in the prophylaxis and treatment of venous thromboembolism: a systematic review. | Current opinion in pulmonary medicine 20040901 |
| Prophylaxis of venous thromboembolism in medical patients. | Current opinion in pulmonary medicine 20040901 |
| Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. | Chest 20040901 |
| Delayed-type hypersensitivity to the ultra-low-molecular-weight heparin fondaparinux. | Contact dermatitis 20040901 |
| New anticoagulants for treatment of venous thromboembolism. | Circulation 20040831 |
| Superiority of fondaparinux over enoxaparin in preventing venous thromboembolism in major orthopedic surgery using different efficacy end points. | Chest 20040801 |
| Challenges in the prevention of venous thromboembolism in the elderly. | Journal of thrombosis and haemostasis : JTH 20040801 |
| Pentasaccharides. The new anticoagulants. | Saudi medical journal 20040801 |
| New trends in anticoagulant therapy. | The Israel Medical Association journal : IMAJ 20040801 |
| Treatment of heparin-induced thrombocytopenia with fondaparinux. | Haematologica 20040801 |
| Fondaparinux: a suitable alternative in cases of delayed-type allergy to heparins and semisynthetic heparinoids? A study of 7 cases. | Contact dermatitis 20040801 |
| [Prevention and treatment of deep vein thrombosis with ximelagatran]. | Deutsche medizinische Wochenschrift (1946) 20040723 |
| Limitations of traditional anticoagulants. | Pharmacotherapy 20040701 |
| Emerging options for thromboprophylaxis after orthopedic surgery: a review of clinical data. | Pharmacotherapy 20040701 |
| Evidence for extended prophylaxis in the setting of orthopedic surgery. | Pharmacotherapy 20040701 |
| Evolving concepts in the treatment of venous thromboembolism: the role of factor Xa inhibitors. | Pharmacotherapy 20040701 |
| Special considerations with fondaparinux therapy: heparin-induced thrombocytopenia and wound healing. | Pharmacotherapy 20040701 |
| Pharmacoeconomics of thrombosis management. | Pharmacotherapy 20040701 |
| A dose-finding study of fondaparinux in patients with non-ST-segment elevation acute coronary syndromes: the Pentasaccharide in Unstable Angina (PENTUA) Study. | Journal of the American College of Cardiology 20040616 |
| A synthetic antithrombin III binding pentasaccharide is now a drug! What comes next? | Angewandte Chemie (International ed. in English) 20040614 |
| [Modern anticoagulation. Problems of the proven, hope for the new]. | Der Internist 20040601 |
| Activity of a synthetic hexadecasaccharide (SanOrg123781A) in a pig model of arterial thrombosis. | Journal of thrombosis and haemostasis : JTH 20040601 |
| Fondaparinux: a Factor Xa inhibitor for antithrombotic therapy. | Expert opinion on pharmacotherapy 20040601 |
| Fondaparinux or enoxaparin for the initial treatment of symptomatic deep venous thrombosis: a randomized trial. | Annals of internal medicine 20040601 |
| Summaries for patients. Fondaparinux or enoxaparin for deep venous thrombosis? | Annals of internal medicine 20040601 |
| Intolerance of fondaparinux in a patient allergic to heparins. | Contact dermatitis 20040601 |
| [The new anticoagulants are here!]. | Revue des maladies respiratoires 20040601 |
| The design of venous thromboembolism prophylaxis trials: fondaparinux is definitely more effective than enoxaparin in orthopaedic surgery. | International journal of clinical practice 20040501 |
| Minor transplacental passage of fondaparinux in vivo. | The New England journal of medicine 20040429 |
| Recombinant factor VIIa partially reverses the inhibitory effect of fondaparinux on thrombin generation after tissue factor activation in platelet rich plasma and whole blood. | Thrombosis and haemostasis 20040301 |
| [Prevention of deep vein thrombosis in surgical departments]. | Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen 20040301 |
| Comparison of the effect of fondaparinux and enoxaparin on thrombin generation during in-vitro clotting of whole blood and platelet-rich plasma. | Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 20040301 |
| Current perspectives on the treatment of venous thromboembolism: need for effective, safe and convenient new antithrombotic drugs. | International journal of clinical practice 20040301 |
| Fondaparinux: a new synthetic and selective inhibitor of Factor Xa. | Best practice & research. Clinical haematology 20040301 |
| [Hemostasis-altering drugs and regional anesthetic techniques: safety guidelines]. | Revista espanola de anestesiologia y reanimacion 20040301 |
| Novel concatameric heparin-binding peptides reverse heparin and low-molecular-weight heparin anticoagulant activities in patient plasma in vitro and in rats in vivo. | Blood 20040215 |
| Fondaparinux in pulmonary embolism. | The New England journal of medicine 20040205 |
| Fondaparinux as a novel therapeutic alternative in a patient with heparin allergy. | Allergy 20040201 |
| Assessment of three chromogenic and one clotting assays for the measurement of synthetic pentasaccharide fondaparinux (Arixtra) anti-Xa activity. | Journal of thrombosis and haemostasis : JTH 20040201 |
| Fondaparinux for symptomatic pulmonary embolism. | The New England journal of medicine 20040108 |
| A cost analysis of fondaparinux versus enoxaparin in total knee arthroplasty. | American journal of therapeutics 20040101 |
| Fondaparinux sodium lacks immunomodulatory effects of heparin. | American journal of surgery 20040101 |
| Arixtra (fondaparinux sodium). | Methods in molecular medicine 20040101 |
| [On fondaparinux and anesthesia ]. | Revista espanola de anestesiologia y reanimacion 20040101 |
| Cost analysis of fondaparinux versus enoxaparin as venous thromboembolism prophylaxis in hip fracture surgery. | American journal of therapeutics 20040101 |
| Treatment of venous thromboembolism: duration and new options. | The hematology journal : the official journal of the European Haematology Association 20040101 |
| [Paradigm change in anticoagulation. Natural substances that are selective factor Xa inhibitors]. | Pharmazie in unserer Zeit 20040101 |
| [Low molecular weight heparin, fondaparinux and melagatran: new data and clinical studies]. | Pharmazie in unserer Zeit 20040101 |
| A cost-effectiveness analysis of fondaparinux sodium compared with enoxaparin sodium as prophylaxis against venous thromboembolism: use in patients undergoing major orthopaedic surgery. | PharmacoEconomics 20040101 |
| Fondaparinux sodium: a review of its use in the prevention of venous thromboembolism following major orthopaedic surgery. | Drugs 20040101 |
| Pharmacoeconomic analysis of fondaparinux versus enoxaparin for the prevention of thromboembolic events in orthopedic surgery patients. | American journal of cardiovascular drugs : drugs, devices, and other interventions 20040101 |
| Advances in DVT prophylaxis and management in major orthopaedic surgery. | Surgical technology international 20040101 |
| [Novel antithrombotic drugs. From the 19th Congress of the International Society on Thrombosis and Haemostasis]. | Kardiologiia 20040101 |
| Current options in the prevention of thromboembolic disease. | Drugs 20040101 |
| Fondaparinux. | The Journal of the American Academy of Orthopaedic Surgeons 20040101 |
| [Prevention and treatment of venous thromboses and thromboembolism: pentasaccharides as novel anticoagulants selectively blocking Xe factor, their position and potential (data of the XIX International Congress on Thromboses and Hemostasis)]. | Angiologiia i sosudistaia khirurgiia = Angiology and vascular surgery 20040101 |
| Venous thromboembolism prophylaxis: role of factor xa inhibition by fondaparinux. | Surgical technology international 20040101 |
| Cost consequence analysis of fondaparinux versus enoxaparin in the prevention of venous thromboembolism after major orthopaedic surgery in Belgium. | Acta clinica Belgica 20040101 |
| Tolerance to the synthetic pentasaccharide fondaparinux in heparin sensitization. | Allergy 20031201 |
| Fondaparinux and prolonged thromboprophylaxis after hip fracture surgery. | Archives of internal medicine 20031201 |
| Advances and contemporary issues in prophylaxis for deep vein thrombosis. | Chest 20031201 |
| New pentasaccharides for prophylaxis of deep vein thrombosis: pharmacology. | Chest 20031201 |
| New pentasaccharides for the prophylaxis of venous thromboembolism: clinical studies. | Chest 20031201 |
| Controversies in timing of the first dose of anticoagulant prophylaxis against venous thromboembolism after major orthopedic surgery. | Chest 20031201 |
| Duration of venous thromboembolism prophylaxis after surgery. | Chest 20031201 |
| [Prevention of venous thromboembolism after major orthopedic surgery: update and contribution of a specific synthetic inhibitor of factor Xa]. | Revue de chirurgie orthopedique et reparatrice de l'appareil moteur 20031201 |
| Delayed-type hypersensitivity skin reactions due to heparins and heparinoids. Tolerance of recombinant hirudins and of the new synthetic anticoagulant fondaparinux. | Contact dermatitis 20031201 |
| [New anticoagulant preparation Arixtra. Experience and perspectives of clinical application]. | Klinichna khirurhiia 20031201 |
| Future therapeutic directions for factor Xa inhibition in the prophylaxis and treatment of thrombotic disorders. | American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20031115 |
| Fondaparinux and prevention of venous thromboembolism after orthopaedic surgery. | Lancet (London, England) 20031108 |
| Fondaparinux and prevention of venous thromboembolism after orthopaedic surgery. | Lancet (London, England) 20031108 |
| Fondaparinux and prevention of venous thromboembolism after orthopaedic surgery. | Lancet (London, England) 20031108 |
| [Synthetic anticoagulation stands the test in internist patients, Thrombosis risk in immobilization cut in half]. | MMW Fortschritte der Medizin 20031106 |
| Fondaparinux for prevention of venous thromboembolism in major orthopedic surgery. | The Annals of pharmacotherapy 20031101 |
| [New anticoagulants in the treatment of venous thrombo-embolic disease]. | La Revue de medecine interne 20031101 |
| Fondaparinux (ARIXTRA) as an alternative anti-thrombotic prophylaxis when there is hypersensitivity to low molecular weight and unfractionated heparins. | Haematologica 20031101 |
| Recombinant factor VIIa reverses the in vitro and ex vivo anticoagulant and profibrinolytic effects of fondaparinux. | Journal of thrombosis and haemostasis : JTH 20031101 |
| Successful use of Arixtra in a patient with paroxysmal nocturnal hemoglobinuria, Budd-Chiari syndrome and heparin-induced thrombocytopenia. | Journal of thrombosis and haemostasis : JTH 20031101 |
| Thrombosis and Hemostasis Issues in Cancer - Second International Conference. 19-21 September, 2003, Bergamo, Italy. | IDrugs : the investigational drugs journal 20031101 |
| Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolism. | The New England journal of medicine 20031030 |
| Treating thrombosis in the 21st century. | The New England journal of medicine 20031030 |
| Effects of fondaparinux compared with dalteparin, enoxaparin and unfractionated heparin on human osteoblasts. | Calcified tissue international 20031001 |
| Short- and long-acting synthetic pentasaccharides. | Journal of internal medicine 20031001 |
| On the mechanism of inhibition of tissue factor pathway by the synthetic pentasaccharide during coagulation of human plasma. | Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 20031001 |
| The cost-effectiveness of fondaparinux compared with enoxaparin as prophylaxis against thromboembolism following major orthopedic surgery. | Journal of thrombosis and haemostasis : JTH 20031001 |
| Best evidence in anesthetic practice: prevention: fondaparinux is better than enoxaparin for prevention of major venous thromboembolism after orthopedic surgery. | Canadian journal of anaesthesia = Journal canadien d'anesthesie 20031001 |
| Mechanism of catalysis of inhibition of factor IXa by antithrombin in the presence of heparin or pentasaccharide. | The Journal of biological chemistry 20030912 |
| Fondaparinux, the first selective factor Xa inhibitor. | Current opinion in hematology 20030901 |
| Antithrombotic properties of a direct thrombin inhibitor with a prolonged half-life and AT-mediated factor Xa inhibitory activity. | Journal of thrombosis and haemostasis : JTH 20030901 |
| Efficacy of pentasaccharide on a prethrombosis model based on a calibrated stasis by the increase in up-stream venous pressure. | Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 20030901 |
| Tolerance of fondaparinux in a patient allergic to heparins and other glycosaminoglycans. | Contact dermatitis 20030901 |
| Prevention of venous thromboembolism after major orthopaedic surgery: is fondaparinux an advance? | Lancet (London, England) 20030816 |
| Fondaparinux and enoxaparin in comparison to unfractionated heparin in preventing thrombus formation on mechanical heart valves in an ex vivo rabbit model. | Thrombosis and haemostasis 20030801 |
| Efficacy and safety of fondaparinux in major orthopedic surgery according to the timing of its first administration. | Thrombosis and haemostasis 20030801 |
| Improvements in the prevention of postoperative venous thromboembolism in hip fracture patients. | Orthopedics 20030801 |
| Advancements in minimally invasive total knee arthroplasty. | Orthopedics 20030801 |
| New drugs 2003, part II. | Nursing 20030701 |
| Duration of prophylaxis against venous thromboembolism with fondaparinux after hip fracture surgery: a multicenter, randomized, placebo-controlled, double-blind study. | Archives of internal medicine 20030609 |
| Selective factor Xa inhibition improves efficacy of venous thromboembolism prophylaxis in orthopedic surgery. | Pharmacotherapy 20030601 |
| Factor Xa is highly protected from antithrombin-fondaparinux and antithrombin-enoxaparin when incorporated into the prothrombinase complex. | Journal of thrombosis and haemostasis : JTH 20030601 |
| [Fondaparinux for thrombosis prevention after orthopaedic surgery: a revolution?]. | Medicina clinica 20030531 |
| [New antithrombotic agents. Towards a new therapeutic plan]. | La Revue du praticien 20030515 |
| Factor X inhibitors. | Expert opinion on investigational drugs 20030501 |
| The design of venous thromboembolism prophylaxis trials: is enoxaparin more effective than fondaparinux? | International journal of clinical practice 20030501 |
| The present and future of heparin, low molecular weight heparins, pentasaccharide, and hirudin for venous thromboembolism and acute coronary syndromes. | Seminars in vascular medicine 20030501 |
| Low-molecular-weight heparins and heparinoids. | The Medical journal of Australia 20030421 |
| Cost analysis: fondaparinux versus preoperative and postoperative enoxaparin as venous thromboembolic event prophylaxis in elective hip arthroplasty. | American journal of orthopedics (Belle Mead, N.J.) 20030401 |
| [New synthetic antithrombotic agent. In secondary prevention conclusive, too]. | MMW Fortschritte der Medizin 20030327 |
| Fondaparinux requires further study before firm recommendation. | Archives of internal medicine 20030224 |
| Influence of the duration of fondaparinux (Arixtra) prophylaxis in preventing venous thromboembolism following major orthopedic surgery. | Journal of thrombosis and haemostasis : JTH 20030201 |
| [New anticoagulants -- their clinical significance]. | Therapeutische Umschau. Revue therapeutique 20030101 |
| [New and future antithrombotic agents in thrombo-embolic venous disease]. | La Revue du praticien 20030101 |
| Evaluation of the pharmacological properties and clinical results of the synthetic pentasaccharide (fondaparinux). | Thrombosis research 20030101 |
| Fondaparinux: a synthetic selective factor-Xa inhibitor. | Heart disease (Hagerstown, Md.) 20030101 |
| [Fondaparinux and anesthesia]. | Revista espanola de anestesiologia y reanimacion 20030101 |
| [Treatment and prevention of venous thromboembolic events: present and future antithrombotic agents]. | Bulletin de l'Academie nationale de medecine 20030101 |
| Two sensitive and rapid chromogenic assays of fondaparinux sodium (Arixtra) in human plasma and other biological matrices. | Clinical laboratory 20030101 |
| Novel anticoagulants for the prevention and treatment of venous thromboembolism. | Wiener medizinische Wochenschrift (1946) 20030101 |
| Orthopedic pearls in deep vein thrombosis: questions frequently asked. | Journal of surgical orthopaedic advances 20030101 |
| Enoxaparin or fondaparinux for thrombosis prevention after orthopaedic surgery. | Lancet (London, England) 20021123 |
| Enoxaparin or fondaparinux for thrombosis prevention after orthopaedic surgery. | Lancet (London, England) 20021123 |
| Fondaparinux versus enoxaparin for prevention of venous thromboembolism. | Lancet (London, England) 20021116 |
| Fondaparinux versus enoxaparin for prevention of venous. | Lancet (London, England) 20021116 |
| Fondaparinux versus enoxaparin for prevention of venous. | Lancet (London, England) 20021116 |
| Ability of recombinant factor VIIa to reverse the anticoagulant effect of the pentasaccharide fondaparinux in healthy volunteers. | Circulation 20021112 |
| Selective factor Xa inhibitors: practical guidelines for use. | American journal of orthopedics (Belle Mead, N.J.) 20021101 |
| Fondaparinux: basic properties and efficacy and safety in venous thromboembolism prophylaxis. | American journal of orthopedics (Belle Mead, N.J.) 20021101 |
| Use of selective factor Xa inhibitors in special populations. | American journal of orthopedics (Belle Mead, N.J.) 20021101 |
| Thromboprophylaxis dosing: the relationship between timing of first administration, efficacy, and safety. | American journal of orthopedics (Belle Mead, N.J.) 20021101 |
| Use of neuraxial anesthesia with selective factor Xa inhibitors. | American journal of orthopedics (Belle Mead, N.J.) 20021101 |
| Fondaparinux: a new antithrombotic agent. | Clinical therapeutics 20021101 |
| Traditional versus modern anticoagulant strategies: summary of the literature. | American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20021015 |
| Fondaparinux (Arixtra): a new anticoagulant. | International journal of clinical practice 20021001 |
| The potential role of fondaparinux as venous thromboembolism prophylaxis after total hip or knee replacement or hip fracture surgery. | Archives of internal medicine 20020909 |
| Fondaparinux vs enoxaparin for the prevention of venous thromboembolism in major orthopedic surgery: a meta-analysis of 4 randomized double-blind studies. | Archives of internal medicine 20020909 |
| Factor Xa inhibition in the prevention of venous thromboembolism and treatment of patients with venous thromboembolism. | Current opinion in pulmonary medicine 20020901 |
| Heparin pentasaccharide. | Current opinion in hematology 20020901 |
| Absence of an interaction between the synthetic pentasaccharide fondaparinux and oral warfarin. | British journal of clinical pharmacology 20020901 |
| Venous thromboembolic disease prophylaxis in patients undergoing orthopedic surgery of the lower extremity. | American journal of orthopedics (Belle Mead, N.J.) 20020901 |
| [Recent therapeutic strategies and new drugs]. | Revue medicale de Bruxelles 20020901 |
| In vitro comparison of the effect of heparin, enoxaparin and fondaparinux on tests of coagulation. | Thrombosis research 20020901 |
| The synthetic pentasaccharide fondaparinux: first in the class of antithrombotic agents that selectively inhibit coagulation factor Xa. | Seminars in thrombosis and hemostasis 20020801 |
| [A new synthetic coagulation inhibitor. Only half as many thromboembolisms]. | MMW Fortschritte der Medizin 20020711 |
| Pentasaccharides. | Seminars in hematology 20020701 |
| The role of thrombin inhibition during percutaneous coronary intervention. | Pharmacotherapy 20020601 |
| Optimizing prophylaxis of venous thromboembolism. | Seminars in thrombosis and hemostasis 20020601 |
| Unresolved issues in the prevention and treatment of venous thromboembolism. | Seminars in thrombosis and hemostasis 20020601 |
| Treatment of symptomatic venous thromboembolism: improving outcomes. | Seminars in thrombosis and hemostasis 20020601 |
| Benefit of selective factor inhibition. | Seminars in thrombosis and hemostasis 20020601 |
| Fondaparinux: a new synthetic pentasaccharide for thrombosis prevention. | Lancet (London, England) 20020518 |
| Postoperative fondaparinux versus preoperative enoxaparin for prevention of venous thromboembolism in elective hip-replacement surgery: a randomised double-blind comparison. | Lancet (London, England) 20020518 |
| Postoperative fondaparinux versus postoperative enoxaparin for prevention of venous thromboembolism after elective hip-replacement surgery: a randomised double-blind trial. | Lancet (London, England) 20020518 |
| Fondaparinux (Arixtra), a new anticoagulant. | The Medical letter on drugs and therapeutics 20020513 |
| Absence of placental transfer of pentasaccharide (Fondaparinux, Arixtra) in the dually perfused human cotyledon in vitro. | Thrombosis and haemostasis 20020501 |
| Fondaparinux versus enoxaparin for the prevention of venous thromboembolism. | Expert opinion on pharmacotherapy 20020401 |
| Prevention of venous thromboembolism with fondaparinux. | The New England journal of medicine 20020321 |
| Prevention of venous thromboembolism with fondaparinux. | The New England journal of medicine 20020321 |
| Prevention of venous thromboembolism with fondaparinux. | The New England journal of medicine 20020321 |
| Prevention of venous thromboembolism with fondaparinux. | The New England journal of medicine 20020321 |
| Fondaparinux: a synthetic heparin pentasaccharide as a new antithrombotic agent. | Expert opinion on investigational drugs 20020301 |
| Arixtra injection. FDA approves synthetic anticlotting drug. | Nursing 20020301 |
| Fondaparinux sodium. | Drugs of today (Barcelona, Spain : 1998) 20020301 |
| [Two new very promising antithrombotic agents: pentasaccharide and ximelagatran]. | Revue medicale de la Suisse romande 20020101 |
| FDA approves synthetic blood thinner. | FDA consumer 20020101 |
| Fondaparinux, a synthetic pentasaccharide: the first in a new class of antithrombotic agents - the selective factor Xa inhibitors. | Cardiovascular drug reviews 20020101 |
| Therapeutic considerations in the management of patients with heparin-induced thrombocytopenia. | Progress in cardiovascular nursing 20020101 |
| Fondaparinux sodium. | Drugs 20020101 |
| The pharmacokinetics of fondaparinux sodium in healthy volunteers. | Clinical pharmacokinetics 20020101 |
| Fondaparinux sodium mechanism of action: identification of specific binding to purified and human plasma-derived proteins. | Clinical pharmacokinetics 20020101 |
| Fondaparinux sodium is not metabolised in mammalian liver fractions and does not inhibit cytochrome P450-mediated metabolism of concomitant drugs. | Clinical pharmacokinetics 20020101 |
| The synthetic pentasaccharide fondaparinux sodium does not interact with oral warfarin. | Clinical pharmacokinetics 20020101 |
| Absence of interaction of fondaparinux sodium with aspirin and piroxicam in healthy male volunteers. | Clinical pharmacokinetics 20020101 |
| Absence of interaction of fondaparinux sodium with digoxin in healthy volunteers. | Clinical pharmacokinetics 20020101 |
| Fondaparinux sodium does not cross the placental barrier: study using the in-vitro human dually perfused cotyledon model. | Clinical pharmacokinetics 20020101 |
| Current anticoagulation options in percutaneous intervention: designing patient-specific strategies. | Reviews in cardiovascular medicine 20020101 |
| Two new antithrombotic agents (fondaparinux and ximelagatran) and their implications in anesthesia. | Canadian journal of anaesthesia = Journal canadien d'anesthesie 20020101 |
| A meta-analysis of fondaparinux versus enoxaparin in the prevention of venous thromboembolism after major orthopaedic surgery. | Journal of the Southern Orthopaedic Association 20020101 |
| A new antithrombotic strategy, the selective inhibition of coagulation factors, and its importance to the orthopedic specialist. | Journal of the Southern Orthopaedic Association 20020101 |
| Cardiovascular news. | Circulation 20011127 |
| Fondaparinux sodium: a selective inhibitor of factor Xa. | American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20011101 |
| Setting a standard for venous thromboembolism prophylaxis. | American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20011101 |
| Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after hip-fracture surgery. | The New England journal of medicine 20011101 |
| Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after elective major knee surgery. | The New England journal of medicine 20011101 |
| Choosing a parenteral anticoagulant agent. | The New England journal of medicine 20011101 |
| Overview of the clinical results of pentasaccharide in major orthopedic surgery. | Haematologica 20011101 |